studocu

Bhalani- Final Part ||

+
MPMSU previous 5 years
(10 papers)
14-18 batch

Red highlights & underline: asked in LONG ANSVWER

Red star :no. of times repeated in L.A

Yellow highlights & blue underline:SHORT ANSWER

Blue star no. of times repeated in S.A

Studocu is not sponsored or endorsed |college or university

Dewsteeded by Yash Dubey
 MPMSU syllabus:

Paper I - General Medicine shall contain questions from: Cardiovascular System, Respiratory
System, Gastrointestinal System, Neurological Diseases, Poisons, Occupational Hazards,
Immune System, Connective Tissue & Joints, Oncology & Hematology

Paper II - General Medicine shall contain questions from: Genetics & Diseases, Nutrition &
Infectious Diseases, Endocrinology & Metabolism, Kidney & Urinary Tract, Psychiatry,
Dermatology, Sexually transmitted Diseases

Medicine-I
Tclinical Immunology Autoimmune antibodies

SAQ Major histocompatibility complex

1. Anaphylactic Shock*** - management; c/f, treatment (S-17) (S-15)(W-13)(S-05) (Pg. 76)

TPoisoning
SAQ
**(celphos poisoning)
-
Organophosphorus Compound Poisoning* ******* c/f****, management****** (S-16)(S-13)
k
1.
(W-12)(W-10)(S-10)(S-06)(W-05)(W-04)(W-03) (Pg. 145)
2. Methanol Poisoning* - c/f*, treatment* (W-13)(S-09) (Pg. 147)
3. Acute Barbiturate Poisoning*- treatment* (S-07)(W-06)

Evenomation
L

SAQ

1. Neurotoxic*/Neuroparalytic** Snake Bite -management*** (S-20)(S-19)(S-13)(S-09)(S-08) (Pg. 159)

2. Vasculotoxic Snake Bite - management (W-17)
3. Poisonous Snake Bite***- management*; c/f",treatment; complications (W-15)(W-12)(S-11) (S-05)
4. Scorpion Sting (W-14) (Pg. 161)
 LAQ

1. Snake Bite - c/f, investigations, complications, treatment (S-14)

Environmental Medicine
SAQ

-
Stroke***** causes, c/t, management* (S-18) (S-12)(S-07)(W-05)(W-04)(W-03) (Pg. 167)
1. Heat
2. Heat Exhaustion (W-11) (Pg. 167)
3. Hypothermia (S-11) (Pg. 165)
4. Hyperthermia(S-03) (Pg. 167)

Acute Medicine andCritical Illness

(T) K(septic shock)
LAQ Sepsis and it's management
(I)
1. Shock - define, types; Cardiogenic Shock - causes, c/f, investigations, treatment (S-07) (Pg. 199)

Infectious Diseases
SAQ
Amoebic liver abscess: c/f, complications, treatment
1. Dengue Shock Syndrome*** - c/f (S-20)(S-19)(W-15)(W-08) (Pg. 243)
Neurologiçal
2. Diphtheria* -management; complications (W-18) (W-10) (Pg. 266)
3. Enteric Fever***/Typhoid Fever** - complications******, treatment*; c/f (W-18)(W-12)(W-11)
(W-07)(S-06) (S-03)(W-02) (Pg. 260)
4. Malarial Chemoprophylaxis* (S-18)(S-09) (Pg. 277)
5. Lepra Reaction**** - treatment (S-18)(W-17) (S-13)(W-07) (W-03) (Pg. 268)
6. Leptospirosis**/Weil's Disease (S-18)(S-09)(W-06) (Pg. 257) C/f & treatment
7. Dengue Haemorrhagic Fever* - treatment (W-17)(W-13) (Pg. 243)
8. Food Poisoning (S-17) (Pg. 262)
9. Malaria/Plasmodium falciparum Malaria** - complications***, treatment (W-16)(S-16)(W-06)(S-03)
(Pg. 276)
10. Ebola Virus Infection; Ebola Fever (S-16)(W-14) (Pg. 246)
11. Viral Haemorrhagic Fevers - causes, treatment (S-15) (Pg. 245)
12. Dengue Fever* -c/F* (W-13) (S-10) Complications and management
13. Kala Azar - c/f, investigations (W-12) (Pg. 282)
14. Cholera* -treatment; fluid replacement (S-11)(W-08) (Pg. 265)
15. Cerebral Malaria ** - treatment**; c/f (S-10)(W-09) (S-03) (Pg. 275)
16. Traveller's Diarrhoea (S-10) (Pg. 232)
17. Hepatic [Amoebic Abscess]* - management* (W-08)(W-03) (Pg. 287)
18. Tropical Splenomegaly (W-08)
19. Mumps* - c/f, D/D, prevention (S-08)(W-03) (Pg. 240)
Cytokine storm
 COVID 19: c/f and complications diagnosis, management
20. Widal Test - interpretation (W-06)
21. Hookworm Infestation* -medical disorders* associated (S-06)(W-02) (Pg. 288)
22. Filariasis - manifestations (W-05) (Pg. 290)
23. Leprosy - principles of management (S-04) (Pg. 267)

LAQ HINI influenza: c/f, diagnosis, complications, management

1. Plasmodium Falciparum* - life cycle*; Malaria* - C/F*,management*; etiopathogenesis (W-18)
(S-15)(S-06) (Pg. 273)
2. Viral Haemorrhagic Fevers - enumerate; Dengue Fever - c/f, complications, treatment (S-14)
3. Complicated* [Falciparum Malaria]* - clinical presentation**, management**; etiopathogenesis,
complications (S-13) (S-08)(W-05)
-
4. Enteric Fever/Typhoid Fever c/f*, management; investigations, complications, treatment (S-12)(S-10)
5. Measles (in adults) - c/f, complications, management; Patterns of Rash -enumerate, causes associated
with infection (S-07) (Pg. 237)
6. Cerebral Malaria- c/f, investigations, complications, management (S-06)
7. Acute Gastroenteritis - define, causes, pathogenetic mechanisms, investigations, management (S-05)
(Pg. 228)
8. Fever with Maculopapular Rash - causes; Rubella - c/f, complications, prevention (S-04) (Pg. 236)
-
9. Diphtheria etiopathogenesis, c/f, investigations, complications (W-02)

HIV Infection and AIDS

Pneumocystis jerovecci
SAQ
Immune reconstitution inflammatory syndrome (IRIS) in HIV

-
1. HIV* positive patient*** diagnostic investigations; baseline** investigations with justification;
laboratory diagnosis (S-20)(S-19)(W-15)(W-07)(S-07) (Pg. 310)
2. CD4 Count (S-17) (Pg.311)
3. AIDS - Pulmonary Infections (S-15)
4. Cryptococcal Meningitis (W-13) (Pg. 321)
5. HIV Opportunistic Infections* - enumerate (S-13)(W-10)
6. AIDS Defining llnesses - enumerate (W-05)
7. Kaposi's Sarcoma (S-05) (Pg. 315)
8. HIV- post-exposure prophylaxis (W-04) (Pg. 327)
K (drug therapy for HIV)

LAQ Acute HIV infection, AlDS WHO classification & management

1. AIDS -Respiratory System involvement (W-19) (Pg. 318)
2. AIDS - CNS manifestations (W-16) (Pg. 319)
3. Opportunistic Infections in AIDS - enumerate, c/t, diagnosis, treatment (W-14) (Pg. 325)
(prophylaxis)
Rhinocerebral mucormycosis: etiopath, c/f, management
Clinical Biochemistry and Metabolic Medicine
SAQ

1. Lipid Lowering Agents*/Drugs*/Cholesterol Reducing Agents* - classification***, use**; indications (S

20)(S-19)(W-15)(S-07) (Pg. 375)

2. Hyperkalemia** - treatment/management (W-19)(S-18)(S-14) (Pg. 362)
3. Hyponatremia** - manifestations, treatment*; c/f (W-16)(S-15)(W-14) (Pg. 357)
4. Metabolic Acidosis (W-12) (Pg. 364)

Cardiology
SAQ

1. Infective*/Bacterial Endocarditis**** - c/F***, prophylaxis; Duke's Criteria (S-20)(S-19)(W-17)(W

15)(S-15)(W-07) (Pg. 527, 531; 529)
2. Atrial Fibrillation*********** - causes**, treatment****,complications; etiology*, c/t;drug
treatment (S-20)(S-19)(W-16)(W-15)(S-14)(W-12)(W-11) (S-09)(W-08)(S-08)(S-06)(S-04) (Pg. 470)
3. Acute Myocardial Infarction** - complications*; management (W-19)(W-17)(S-14) (Pg.495)
4. Mitral Stenosis -complications (W-18) (Pg. 517) & clinical features
5. Jugular Venous Pulse (W-17) (Pg. 443)
6. Hypertension - principles of management (S-17) (Pg. 510)
7. Marfan's Syndrome (S-17) (Pg. 508)
8. Ventricular Premature Beats (S-17) (Pg. 474)
-
9. Dilated Cardiomyopathy* causes, investigations; c/f, diagnosis (W-16)(S-15) (Pg. 539)
10. Unstable Angina (S-16)
11. Acute RheumaticFever* - c/f, treatment; diagnostic criteria (W-13)(W-09) (Pg. 515)
12. Supraventricular Paroxysmal Tachycardia (S-12) (Pg.473)
13. Cardiopulmonary Resuscitation (W-11) (Pg. 458)
14.Subacute Endocarditis -C/F (W-10) (Pg. 528)
15. Thrombolytic Drugs (W-09) (Pg. 500)
16. Aortic Regurgitation - c/F (W-09) (Pg. 524)
17.Cardiac Tamponade (S-08) (Pg. 544)

LAQ
(Non STEMI) (Acute coronary syndrome)
1. Acute MI*******/Uncomplicated MIwithin 6 hours of chest pain - RF*,C/F*******
investigations**** **, management*****, medical management**, complications*; diagnostic work
up (5-20)(S-19)(W-15(W-10](W-08 5-06(W-04)(W-02) (Pg. 493)
2. Heart Failure**/Congestive Cardiac Failure**/Acute Left Ventricular Heart Failure** - define,
etiopathogenesis*; causes*, C/F******} types*, predisposing conditions, lab investigations***,
imaging modalities, management*****, medical management of CCF due to Rheumatic Heart Disease
(W-19)(W-17) (\W-14J(\w-IZ]|W-1I(S-09)(S-08)(W-03) (Pg. 461)
3. Infective Endocarditis***- etiology*, pathology, c/E***, diagnosis, investigations, treatment*; Sub
Acute Endocarditis** -complications, investigations* in diagnosis, management**; pathogenesis,
clinical presentations (W-186-18|S-17)(5-16)(W-06) (Pg. 527) Risk factors
 -
4. Essential Hypertension/Systemic Hypertension RE, C/F*, investigations*, complications, management;
treatment (S-15)(W-13) (Pg. 508)
5. Acute Rheumatic Fever***- etiopathogenesis**, c/f* **, investigations* **, management*** (S-13)
() (S-11)(W-07)(S-03) (Pg.515) (RHD), Complications
6. Pericardial Effusion* - etiology, c/f, investigations; pathophysiological basis of clinical presentations;
Tubercular Pericardial Effusion - treatment (W-09)(W-05) (Pg. 543, 590)
7. Cardiac Arrhythmia - define; Supraventricular Tachyarrhythmia - enumerate, clinical presentation;
Permanent Atrial Fibrillation in patient with MitralValve Disease - management (S-05)
8. Conductive Tissue of heart - diagrammaticrepresentation; Cardiac Conduction & Rhythm Disorders
-

classify; Ventricular Tachycardia - etiology, diagnosis, management (S-04)

Endocrinology
SAQ Thyroid disorders

1. Thyrotoxicosis*** - C/F***, management** (S-20)(S-19)(\W-15)(W-08) (Pg.635)

2. latrogenic [Cushing's Syndrome]** - c/f* (W-18)(W-11)(S-04) (Pg. 666)
3. Hyperaldosteronism (S-18) (Pg. 674)
4. Adrenal Insufficiency/Addison's Disease*** - c/F**; treatment (S-17)(\W-16)(S-16)(W-10)(S-08) (Pg.
672)
5. Hypopitutarusm (S-16) (Pg. 681) (c/f)
6. Turner'sSyndrome* (S-16)(W-14) (Pg. 659)
7. Klinefelter's Syndrome - C/F (W-13) (Pg. 660)
8. Thyroid Storm**/Thyrotoxic Crisis - management (S-13)(W-11)(W-06)(W-05) (Pg. 639)
9. Hypocalcemia** (W-12)(W-11)(S-07) (Pg.662)
10. Diabetes Insipidus* (S-12)(W-04) (Pg. 687)
11. Tetany*** (S-12)(S-10)(S-06)(S-04)
12. Acromegaly*** - c/E**;investigations* (S-10)(S-06)(W-04)(W-02) (Pg. 685)
13. Hypercalcemia - causes, treatment (S-09) (Pg. 661)
14. Gynaecomastia (W-08) (Pg. 657)
15. Thyroid Hormone Synthesis* (and Regulation) and Pharmacological Interventions based on it (S-07)
(W-02) (Pg. 634)
16. Water Deprivation Test (S-04) (Pg. 688)
17. Graves' Disease (S-03)

LAQ Hyperthyroidism: Etiology, c/f, investigations, management

-
1. Graves' Disease c/f*, investigations*, management; causes (S-15) (W-03) (Pg. 643)
2.Hypothyroidism ***-causes*, c/f**, investigations*, treatment**; etiology; diagnosis; Myxoedema
Coma -management (S-14)(W-13)(W-10)(\W-03) (Pg. 639) (assessment of response to treatment)
3. Addison's Disease* and Acute Adrenal Crisis - etiopathogenesis", c/t", management; investigations,
management (W-12)(S-05) (Pg. 672)
4. Cushing's Syndrome - etiology, c/f, treatment (S-11)
Investigations
Nutritional Factors in Disease
SAQ

1. Vitamin A* (S-20)(S-19) (Pg. 712)

2. Thiamine Deficiency (W-15) (Pg. 714)

Diabetes Mellitus
SAQ Dapagliflozin

1. Metformin (S-20)(S-04) (Pg. 746)

2. Oral Hypoglycemic Agents (S-19) (Pg. 746)
3. Hypoglycemia* - c/t, treatment (W-18) (S-15) (Pg. 738)
4. Diabetic Ketoacidosis**/Ketotic Coma - diagnosis, treatment; management (S-18)(W-13)(S-08)(W-07)
(Pg. 736)
5. Glycosylated Haemoglobin (W-17) (Pg. 726)
6. Sulfonylureas (W-15) (Pg.
7. DM%- Microvasçular Complications; vascular complications (S-15)(W-05) (Pg. 755)
8. Metabolic Syndrome* - RE, Complications; Non-Pharmacological Treatment (S-15)(S-14) (Pg. 730)
9. Insulin Analogues**/Therapy (W-12)(\W-11)(W-07)(S-07) (Pg. 748)
10. Newly Detected Diabetic - work-up, treatment (W-10)
11. Diabetic Nephropathy* (S-06)(w-02) (Pg. 757)

LAQ
(newtreatment modalities) (T1DM: etiopath and management)
1. Diabetes Mellitus*****/Type | DM/NIDDM classify***, types, C/E****, investigations*,
complications****treatment**; diagnosis, management* (S-20) (S-19)(S-17)(S-16)(W-15)(W-08)(W
06) (Pg. 722) (diagnoste eriteria\+Newer OHAs)
Diabetic Ketoacidosis****** etiopathogenesis*, C/F**, investigations, management****;
treatment*"*; diagnosis; pathophysiology (W-19)(S-17)(W-16)(S-11)(S-10(W-09)S-03) (Pg. 735)
3. Diabetes Mellitus/Type I| DM - chronic* complications in poorly controlled DM; microvascular
complications; acute complications (W-18)(W-17)(W-14) (Pg. 755)
4. Diabetic Nephropathy - C/F, investigations, prevention (W-17) (Pg. 757)

Gastroenterology
SAQ

-
1. Gastroesophageal Reflux Disease/GERD*** treatment (S-20)(W-19)(S-19)(W-14)(S-13) (Pg. 793)
2. Acute Pancreatitis******- laboratory abnormalities; complications; symptoms, D/D, management***;
RE, c/f; causes, systemic complications (W-19)(S-14)(S-07)(S-06)(W-04)(W-03)(W-02) (Pg. 837; 838)
3. Irritable Bowel Syndrome* - medical management (S-18)(S-14) (Pg. 824)
4. Haematemesis* - causes (W-17) (W-13) (Pg. 780)
5. Chronic Constipation - management (W-16) (Pg. 786)
 -
6. Dysphagia causes, investigations (W-16) (Pg. 778)
7. Chronic Pancreatitis**- c/f*; causes, complications (W-16)(W-14)(S-05) (Pg. 839)
8. Acid Peptic Disease - management (S-16) (Pg. 800)
9. Upper GI Bleed** -causes*; management (S-15)(S-14)(W-03) (Pg. 780)
10. Active [Ulcerative Colitis]***** - complications; medical management; treatment;extra-intestinal
manifestations; management (W-13)(S-09)(S-08)(S-05)(S-04)(S-03) (Pg. 818; 820)
11. PepticUlcer**** - treatment*; c/f; medical management* (S-13)(S-10)(W-09)(W-06) (W-05)
12. Topical Sprue* (S-12) (W-03) (Pg. 807)
13. Abdominal Tuberculosis - clinical presentation (W-05) (Pg. 812)
14. H. Pylori Infection (W-04) (Pg. 798)
15. Chronic Diarrhoea (W-04) (Pg. 783)
16. Reflux Esophagitis* - c/f, management (S-04)(S-03) (Pg. 792)
17. Toxic Megacolon - management (S-03)

LAQ
Inflammatory bowel disease: describe
Peptic Ulcers* - causes/etiology*, C/F, complications, investigations, management; Duodenal Ulcer*
-
1.
management*; etiology, pathogenesis, c/f, investigations (S-17)(W-07)(S-07) (Pg. 798)
2. Tuberculosis of lntestines - complications; Tuberculosis of Abdomen* - presentation, investigations*,
management; c/f, treatment (W-16)(W-13) (Pg. 812)
K3. Ulcerative Colitis - c/f, investigations, treatment (S-11)
4. Upper GI Bleeding - causes, c/f, evaluation, treatment (S-10)
5. Acute Pancreatitis - etiology, pathophysiology, c/f, management (W-09)

Hepatology
SAQ
Chronic hepatitis treatment
1. Hepatic Encephalopathy*****/Hepatic Coma* - treatment**/management*; principles of
management** (W-19)(S-17)(S-16)(W-14)(W-09)(S-09)(S-06)(W-02) (Pg. 864)
2. Toxic Hepatitis*; Drug-Induced Hepatitis - causes (W-19)(W-16)(W-14) (Pg. 894)
Non-Alcoholic Steatohepatitis (W-18) (Pg. 882) & Complications
4. Hepatitis B****- management; prevention**; extra-hepatic manifestations; complications (W-18) (W
12)(W-11)(S-11)(S-10)(S-04) (Pg. 875)
5. Liver Cell Failure - clinical signs (W-17) (Pg. 857)
-
6. Bleeding Oesophageal Varices* treatment* (W-15)(W-03) (Pg. 869)
7. Cirrhosis of Liver - complications (S-15) (Pg. 866)
8. Acute Variceal Bleeding* - management; manifestations (W-13)(W-08) (Pg. 865)
9. Portal Hypertension - complications (W-07) (Pg. 868)
10. Estimation of Various Liver Enzymes in Diagnosis (S-07) (Pg. 852)
-
11. Obstructive Jaundice/Cholestatic Jaundice investigations; causes, c/f (W-06)(S-05)
12. Alcoholic Liver Disease - pathogenesis, pathology, c/f (S-05) (Pg. 880)

LAQ
(types, management, complications)
1. Jaundice** - causes; diagnostic approach* (Pg. 860); Hepatitis B - pathogenesis, C/F, treatment (S
20)(S-19)(W-05) (Pg. 873)
 2. Portal Hypertension** - classification, etiology*, c/F, complications, intrahepatic causes, pathogenesis,
medicalmanagement; Oesophageal Varices* - management*; c/f, complications (S-18)(S-04)(S-03) (Pg.
868)
-
3. 45 Year old male presented with Jaundice and Ascites discuss differential diagnosis; Alcoholic Liver
-
Diseases investigations, complications, treatment (W-15) (Pg. 860, 862, 880)
4. Hepatic Coma** - etiopathogenesis, c/f, investigations*, treatment**; precipitating factors (S-13)(S
06)(W-02) (Pg. 864)
Ascites* types, etiology, c/t, investigations, evaluation, management; Tuberculosis Ascites - treatment
-
5.
(W-11)(W-06) (Pg. 862)
6. Hepatotrophic Viruses - list, Acute Viral Hepatitis - C/E, Chronic Heptatitis B - treatment (W-09)
7. Cirrhosis of Liver* - etiopathogenesis, c/t, complications, management; classify, define (S-08)(W-02)
(Pg. 866)
8. Hepato-cellular Failure - signs (part) (S-06)

Hematology and Transfusion Medicine

SAQ

1. Iron Deficiency Anemia**** -c/E***, investigations*; management (S-20)(S-19)(W-15) (S-07)(\W-06)

(Pg. 940)
2. Paroxysmal Nocturnal Hemoglobinuria - C/F (W-19) (Pg. 950)
3. Thrombocytopenia** - causes**;treatment (W-19)(S-17)(W-14) (Pg. 929)
4. Transfusion Reactions**** - enumerate (W-19)(W-12)(W-11)(W-10)(S-07) (Pg. 931)
W5. Sickle Cell Disease -C/F, complications (W-18) (Pg. 951)
6. Megaloblastic Anemia***** - neuropsychiatric features; treatment*; c/f, investigations (W-18)(S
16)(S-13)(S-11)(S-10)(W-07) (Pg. 944)
7. Autoimmune Hemolytic Anemia (S-18) (Pg. 949)
8. Hodgkin's Lymphoma***** - clinical staging****; treatment; management; indications of radiography
and chemotherapy (W-17)(W-10)(W-09)(S-08)(W-07)(\W-03) (Pg. 962)
9. Pernicious Anemia** -treatment (S-17)(S-06)(W-02)(Pg. 944)
10. Fractionated Heparins (W-16) (Pg. 938)
11. Non-Hodgkin's Lymphoma (S-16) (Pg. 964)
12. Disseminated Intravascular Coagulation - causes, management (S-14) (Pg. 978)
-
13. Chronic Myeloid Leukemia******* management; diagnosis, treatment****; peripheral blood smear*
(S-14)(W-13)(S-12) (S-09)(W-06)(S-06)(W-04)(W-02) (Pg. 958)
14. Folate Deficiency* in Adults - causes*, treatment;diagnostic features (S-14)(S-05) (Pg. 945)
15. Idiopathic Thrombocytopenic Purpura* - c/f, treatment (W-13)(W-04) (Pg. 971)
16. Multiple Myeloma* -c/F* (S-13) (S-10) (Pg. 966)
17. Acute Myeloid Leukemia - C/F (S-11) (Pg. 955)
18. Hemophilia* -c/t, treatment (W-10)(S-03)
19. Microcytic Hypochromic Anemia* - differential diagnosis; causes (W-09) (S-07)
K20.Aplastic Anemia (S-08) (Pg. 968) Etiopath & C/F Treatment
21. Hemolytic Anemia - investigations (W-05) (Pg. 945)
22. Philadelphia Chromosome (W-05) (Pg. 958)
-
23. Hodgkin's and Non-Hodgkin's Lymphoma differences (W-05)
24. Bone Marrow Examination (S-05) (Pg. 920)
-
25. Beta Thalassemia diagnostic features, treatment (S-05) (Pg. 953)
 26. Vitamin B12 Deficiency - causes, complications (W-03) (Pg. 944)
27. Acute Lymphoblastic Leukemia - principles of management (S-03) (Pg. 955)
28. Hemoglobinopathies - types, one example of each; Painful Crisis in Sickle CellAnemia - treatment
(S-03) (Pg. 951)

LAQ

1. Chronic Myeloid Leukemia** -cytogenetics, C/E**, diagnosis, treatment; investigations, management*

(S-18)(W-11)(W-07) (Pg.958)
2. Anemia - classify; Nutritional Anemia -c/F, investigations, management (W-17) (Pg. 940)
3. Hemophilia A - etiology, c/f, management (S-16) (Pg. 971)
4. Hodgkin's Disease - classify, c/f, treatment (W-12)
5. Leukemia* - classify* (part) (W-11)(w-07) Complicaions
6. Megaloblastic Anemia* - c/*, diagnosis, treatment*; causes, investigations (W-10)(W-09) (Pg. 944)
Thrombocytopenia causes; ldiopathic Thrombocytopenic Purpura - c/f, diagnosis, management (S-09)
-
7.
8. Hemolytic Anemias - classify; Sickle CellAnemia* - c/f*, complications, management*; pathophysiology
(W-04)(W-03) (Pg. 946;, 951)

Nephrology
SAQ

1. Urinary Casts (S-12)

LAQ

1. Chronic Renal Failure - etiology, c/f, management (S-12) (Pg. 415)

2. Acute Renal Failure - causes, c/f, investigations, management (S-10) (Pg. 411)

Respiratory System
SAQ

1. Pulmonary Hypertension (S-18) (Pg. 621)

2. Tropical Eosinophilia* (W-11)(W-07) (Pg. 612)
3. Pulmonary Embolism - diagnosis (W-09) (Pg. 619)
4. Tuberculous Peritonitis (S-08) (Pg. 590)

Neurology
SAQ

1. Tetanus*** - causes, prevention; treatment; c/t;grading (W-18)(S-11)(W-10)(S-03) (Pg. 1125)

 2. Rabies** - post-exposure prophylaxis*; c/f; Bite of Unobserved Stray Dog -treatment (W-12)(W-10) (S
03) (Pg. 1122)
3. Myasthenia Gravis (S-12) (Pg. 1141)

LAQ

1. Hemiplegia - etiology, c/f, management (S-12)

Stroke Medicine
SAQ

-
1. Subarachnoid Haemorrhage management (W-09) (Pg. 1160)

Rheumatology and Bone Disease

SAQ

1. Hyperuricemia (S-12) (Pg. 1012)

Psychiatry
SAQ

1. Serotonin Syndrome (W-19) (Pg. 1199)

Drugs
SAQ

1. Metformin (S-20)(S-04) (Pg. 746)

2. Digoxin (S-17)
3. Methotrexate (W-16)
4. Amiodarone (W-14)
5. Newer Anti-TB Drugs (S-13)
Angiotensin Receptor Blockers* (S-13)(W-06)
6.
7. Sodium Valproate (S-12)
8. Aspirin (S-12)
9. Streptokinase (S-11)
10. Thrombolytic Drugs (W-09)
11. Protease Inhibitors (HIV) (S-09)
12. Digoxin Toxicity (W-08)
13. Chloroquine (W-07)
Untitled
SAQ

1. Deep Vein Thrombosis - management (W-19)(Pg. 186)

2. Purpura - causes, C/F (W-18)
3. Down's Syndrome (S-18)
4. Refractory Ascites (S-14)
5. Hyperuricemia (S-12)
6. Genetic Counselling* (S-11)(W-06)
7. Tropical Splenomegaly (W-08)
8. Genetic Screening (S-08)
9. Widal Test - interpretation (W-06)
10. Electric Shock and Lightning Injury (S-05)
11. Paroxysmal Nocturnal Dyspnoea (W-04)
12. Human Genome Project (S-04)
13. Severe Acute Respiratory Syndrome [SARS] (S-04)
14. Hepato-splenomegaly - causes (W-03)
 Medicine - I|

Nephrology
SAQ

.-
1. Proteinuria **** causes***, diagnosis* (S-20)(W-16) (S-16)(W-13)(W-08) (Pg. 392)
2. Adult Polycystic Kidney Disease (W-19) (Pg. 405)
3. Acute Pyelonephritis* - c/f, management (W-19)(S-04) (Pg. 430)
4. Hemodialysis**** - indications**; contradiction;Dialysis - types (W-18)(W-17)(W-12)(W-10)(S-05) (Pg.
422)
5. Acute Glomerulonephritis (S-18) (Pg. 397)
6. Nephrotic Syndrome* - causes*, c/f, investigations (W-17)(W-09) (Pg. 393)
7. Pre-Renal Azotemia (S-15)
8. Renal Replacement Therapy (W-14) (Pg. 420)
9. Renal Function Tests* (W-14)(W-11)
10. Chronic Renal Failure*- management; causes (S-14)(W-07) (Pg. 415)
11. Role of Kidney in Hypertension (W-13)
12. Asymptomatic Bacteriuria (S-12) (Pg. 429)
13. NephroticSyndrome** - causes*, investigations; diet (W-10)(W-09)(S-04) (Pg. 395)
14. Acute Renal Failure* - causes; medical causes, complications of Oliguric Phase (S-09)(W-02) (Pg. 411)
15. Microalbuminuria* (S-08)(W-07) (Pg. 394)
16. Renal Osteodystrophy* (W-06)(W-05) (Pg. 418)
17. IgA Nephropathy (Berger's Disease) (S-06) (Pg. 400)
18. Steroids in Rernal Diseases (S-05)
19, Hematuria* - causes (W-04)(W-03) (Pg.391)
20. Minimal Change Disease (S-03) (Pg. 398)
21.GFR- define, formula to calculate GFR (W-02) (Pg. 386)

LAQ

K1. Chronic Kidney Disease**/End Stage Renal Disease/Chronic Renal Failure******, - define, causes ****,
c/f******, management*****; etiology****, investigations**; etiopathogenesis, prevention of
progression; complications, conservative management* (diet & drugs) (non-dialysis management) (S
20)(W-19)(S-18|(S-17)(W-16)(S-12)(W-11) (S-09)(W-08)(S-07)(W-03) (Pg. 415)
2. Renal Replacement Therapy*** - add a note*** (part) (S-20)(W-16)(W-11)(W-08) (Pg. 420)
'3. Acute Kidney Injury/Acute Renal Failure******types, etiology******, c/f****** investigations****
management****; complications; Acute Tubular Necrosis - pathogenesis, investigations, management
(S-19)(S-16)(W-12)(W-09)(S-06)(W-05)(S-04) (Pg. 411)
*4. Nephrotic Syndrome***** - define, causes"/etiology**. c/f****, investigations*,treatment*;
etiopathogenesis, management***; evaluation (W-18) (\W-15)(S-14)(S-11)(S-10)(W-07) (Pg. 395)
5. Acute Glomerulonephritis - etiology, c/f, investigations, management (W-17) (Pg. 397)
6. Hematuria* - define*, causes*,approach* (S-15)(S-08) (Pg. 391)
7. UTI -etiology, c/t, investigation, treatment (W-14) (Pg. 427) (in pregnancy)
8. Chronic Pyelonephritis - etiology, diagnosis, management, advice (W-13) (Pg. 430)
9. Glomerulonephritis - define; Acute PSGN - etiopathogenesis, investigations, management (S-03)
Membranous glomerulonephritis: causes and treatment
Respiratory Medicine
SAQ

1. Bronchial Asthma** - management; lnhaler Therapy; Aerosols (S-20)(S-07)(S-05) (Pg. 567)

2. Haemorrhagic Pleural Effusion (S-20)
3. Pneumothorax**/Tension Pneumothorax* - treatment; signs (W-19)(W-18)(W-17)(S-11)(W-10)(S-03)
(Pg. 625)
4. Acute Severe Asthma***/Status Asthmaticus* - management**; treatment** (W-19)(W-17)(S-17)
(W-09)(W-05)(S-04) (Pg. 572)
5. Atypical Pneumonia (S-19)
6. Bronchoalveolar Lavage (W-18)
RK. Pulmonary Function Tests* in COPD (S-18)(S-12) (Pg. 555, 575)
8. Bronchiectasis (W-16)(W-08) (Pg. 578)
9. Acute Bronchial Asthma (W-16)
10. Hypersensitivity Pneumonitis - causes (S-16) (Pg. 616)
11. Pulmonary Embolism - c/f (S-16) (Pg. 619)
12. Pneumonia* - causes, classification; c/f (S-15)(S-09) (Pg. 582)
13. Interstitial Lung Disease* (S-15)(W-08) (Pg. 605)
14. Community Acquired Pneumonia - c/f (W-14) (Pg. 582)
15. Hydropneumothorax (W-14)
16. Breath Sounds - enumerate with Lung Disease (W-13)
17. Respiratory Dyspnoea (W-13) (Pg. 557)
18. Byssinosis (Cotton Dust) (W-13) (Pg. 614)
19. Clubbing**- grading, causes (W-12)(S-10)(W-02) (Pg. 559)
20. Pneumoconiosis (S-10) (Pg. 614)
-
21. Pleural Effusion c/f (S-08) (Pg. 562)
22. Chronic Bronchitis (S-08) (Pg. 573)
23. Pneumocystis cariniPneumonia (W-07)
24. Respiratory Failure - classification, causes (S-7) (Pg. 565)
-
25. Lung Abscess management (S-07)
26. Farmer's Lung (W-06) (Pg. 616)
27. Legionnaires' (W-06)
28. Cystic Fibrosis - complications, management (S-06) (Pg. 580)
-
29. Bronchogenic Carcinoma c/f (W-05) (Pg. 599)
30. Haemoptysis - causes, treatment (S-04) (Pg. 559)
31. Tropical Pulmonary Eosinophilia (W-03) (Pg. 612)

uberculosis
Tuberculosis: CNS effects
SAQ

1. MDR Tuberculosis*********- treatment**/drugs* therapy; diagnosis (S-20)(S-19)(S-18)(S-17)(W

16)(S-13)(W-09)(S-09)(W-07)(W-04)(W-02) (Pg. 595; 592)
2. Primary Pulmonary Tuberculosis** - clinical manifestations; complications, sequelae (W-19)(W-11)(S
03) (Pg.590)
3. Military Tuberculosis - treatment (S-14)
4. DOTS* - pitfalls; DOTS Plus (W-12)(\W-11)(S-10)(S-05) (Pg. 594)
 5. Extra-Pulmonary TB (S-12) (Pg. 590)
6. Koch's Abdomen - c/f, investigations (S-09) (Pg. 590)
-
7. Tuberculosis chemoprophylaxis (W-06)
8. Primary Complex in Tuberculosis* (S-06)(W-02)
9. Newer Anti-TB Drugs (S-05)
10. RNTCP - categories, treatment regimens (W-03)

LAQ
COVID 19 pneumonia &, treatment
1. Community Acquired Pneumonia** - name, etiology, c/f, management*, complications; Lobar
Pneumonia* - c/f*, investigations, management*; causative agents (W-19)(W-17)(W-12)(W-07) (Pg.
582)
2. Bronchial Asthma*****- describe allergic cascade; define tiopathogenesis ***, c/f***,
management***; pathological changes; Acute Severe Bronchial Asthma/Status Asthmaticus*
management** (S-19)(W-15)(S-15)(W-10) (S-09)(W-04)(W-02) (Pg. 567) Diagnosis
COPD** - define**; clinicalpicture, management; Chronic Bronchitis & Emphysema - etiology, c/f,
management; differences; Chronic Bronchitis- treatment of chronic exacerbation (W-18) (S-17)(S-12)
(Pg. 573) Diaanosis
- -
Pleural Effusion* etiology*, c/f*, investigations, management; D/D; Tuberculous Pleural Effusion
management (S-18)(W-11) (Pg. 562) (Unilateral) Lungs consolidation: clinical findings
5. Pneumonia** - classify**, RF, c/f, management; Hospital Acquired Pneumonia - c/f, management
(W-16)(W-12)(W-09) (Pg. 582; 585)
6. Bronchiectasis***** - causes/etiology, pathophysiology, c/f****; investigations, management****;
complications; etiopathogenesis*; diagnosis (S-16)(S-11)(S-10)(S-08)(S-04)(W-03) (Pg. 578)
-
7. Haemoptysis etiology, c/f, management (W-13) (Pg. 559)
8. Lung Abscess* - etiopathogenesis*, c/f", management*; investigations (W-08)(S-03)
9. What are Suppurative Lung Diseases (part) (S-08)
10. Acute Bacterial Pneumonia - pathogenesis, investigations, principles of management (S-05)

H
Rheumatology and Bone Disease
SAQ

1. Ankylosing Spondylitis**** - c/f* (S-20)(W-19)(W-16)(W-11)(W-05) (Pg. 1030)

2. Rituximab (W-18) (Pg. 1006)
3. Rheumatoid Arthritis*** ** - c/f*; treatment; management**; extra-articular manifestations (S-18)
(S-14)(W-12) (S-12)(W-09)(W-07) (Pg. 1021) Auto antibodies
4. SLE********* - complications; enumerate six criteria; c/f***; extra-articular manifestation*;
investigation, treatment (S-18)(S-16)(W-15)(S-15)(W-14)(S-14) (W-11)(S-09)(S-08)(W-03) (Pg. 1034)
5. CREST Syndrome - components (S-16) (Pg. 1037)
6. Osteomalacia* (W-15)(S-13) (Pg. 1051)
7. DMARDS; Disease Modifying Agents for RA (W-15)(S-08) (Pg. 1004)
8. Rickets (W-14) (Pg. 1051)
9. Charcot's Joint (W-13)
10. Scleroderma (S-13) (Pg. 1037)
11. Seronegative Spondyloarthropathy* (S-11)(W-04) (Pg. 1028)
12. Rheumatoid Factor* (S-10)(S-06) (Pg. 991)
 13. Temporal Arteritis (S-10) (Pg. 1042)
14. Raynaud's Phemomenon (W-07) (Pg. 1035, 1038)
15. Takayasu Arteritis (S-04) (Pg. 1041)

LAQ

*
1. Rheumatoid Arthritis***** etiology* etiopathogenesis", pathophysiology, c/f*****,
treatment/management; pathogenesis; extra-articular manifestations*; investigations*, treatment;
diagnosticcriteria, complications; DMARDS & Biological Newer Agents in treatment; deformities
(S-19)(W-14)(5-07)(\W-06)(W-05)(S-05)(W-02) (Pg. 1021)
2. Systemic Lupus Erythematosus (SLE) - c/f, diagnosis, management (S-06) (Pg. 1034)

Neurology
SAQ

-
1. Parkinsonian/Parkinson's Disease**** treatment; c/f*; drug therapy** (S-20)(W-18)(S-18)(W-16)(W
14)(S-07) (Pg. 1113)
2. Myasthenia Gravis***** -management*; c/f* (S-20)(W-17) (W-16)(S-15)(S-14)(S-06) (Pg. 1141)
3. Migraine - c/f (W-19) (Pg. 1095)
4. Subacute Combined Degeneration of Spinal Cord (S-19) (Pg. 1138)
5. Multiple Sclerosis (S-19) (Pg. 1106)
6. Newer Anti-Epileptic Drugs (S-19) (Pg. 1102)
7. Spinal Cord Disease - clinical localization (W-18)
8. Bell's Palsy* (W-18)(S-11) (Pg. 1082)
9. Cerebellar Syndrome (W-17) (Pg. 1141)
10. Brown Sequard Syndrome - c/f (S-16) (Pg. 1083)
11. Pyridostigmine (W-15) (Pg. 1143)
12. Cerebellar Signs; Cerebellar Syndrome - clinical signs (W-13)(W-09)
13. Seizures - classification (W-13) (Pg. 1098)
14. Trigeminal Neuralgia* (S-13)(W-02) (Pg. 1096) Treatment
15. Status Epilepticus** - management*; define (W-12) (S-10) (S-03) (Pg. 1080)
16. Duchenne Muscular Dystrophy (W-11) (Pg. 48, 1143)
17. Guillian Barre Syndrome (S-09) (Pg. 1140)
18. Disorders of Gait (S-08) (Pg. 1086)
19. Neurosyphillis (W-07) (Pg. 1125)
20. Cluster Headache (S-06) (Pg. 1096)
21. Neurogenic Bladder (W-05)
22. Maintenance of Tone (W-04)
23. Chorea (S-04) (Pg. 1085)
24. UMN lesion & LMN lesion - differentiate (W-02) (Pg. 1082)

LAQ Diabetic neuropathy: types

1. Paraplegia - causes, c/f, investigations (S-20)

2. Parkinsonism* - define*, etiology, c/f, management; Parkinson's Disease - pathophysiology, c/f,
management (W-19)(W-10) (Pg. 1112)
 Tubercular meningitis: C/F

3. Acute Meningitis - treatment; TBM - c/f, investigations, management (W-18) (Pg. 1118, 1120)
4. Acute (Bacterial/Pyogenic Meningitis]** - etiology*,c/f**, investigations, management**; diagnosis,
etiopathogenesis (S-18)(S-14) (S-09) (Pg. 1118)
5. Acute Viral [Traverse Myelitis]** - etiology***, c/f***, investigations*, management**; diagnosis
(W-17)(W-15)(W-05) (S-03) (Pg. 1110)
6. UMN and LMN paralysis* - differences*; Peripheral Neuropathy*** -causes*/etiology, c/f**,
investigations*, management*;classification (W-16)(S-13) (S-10)(W-04) (Pg. 1082; 1138)
7. A 32 year old Alcoholic Male presents with Sudden Weakness of Left Half of body with Slurring of
Speech. Discuss Differentials and approach to Investigations and Management. (S-06)
8. Acute Symmetrical Paraparesis - D/D (part) (W-15)
9. Guillian Barre Syndrome*** - define, investigations, treatment; etiology, c/f**, management**
(S-15)(S-14)(S-07)(W-04) (Pg. 1140) D/D
-
10. GTCS c/f, investigation, treatment (W-14) (Pg. 1099)
11. Brain Abscess - etiology, c/f (W-13) (Pg. 1124)
12. Non-Compressive Myelopathy - causes; Describe various Tracts in Spinal Cord and Localization of
Paraplegia (S-12)
13. Epilepsy - etiopathogenesis, classification, management; Status Epilepticus - management (S-11) (Pg.
1097) (types of seizure disorders) Define seizures
14. Compressive Myelopathy - causes; Paraplegia - cliical approach;Localization of Lesion in Spinal Cord
(W-09)
15. Cerebellar Disorders - neurological signs (S-08)
16. Acute Onset Paraplegia* - causes*; Paraplegia - causes (part) (S-07) (W-05)(S-03)
17. Amyotrophic Lateral Sclerosis - etiopathogenesis, c/f, D/D, management (W-06) (Pg. 1116)
18. Acute Infective Polyneuritis - define, investigations, treatment (S-05)

Stroke Medicine
SAQ

Acute Thrombotic Cerebrovascular Episode - RF (W-19) (Pg. 1153)

1.
2. Transient Ischemic Attack* (S-17)(W-10) (Pg. 1156)
3. Lacunar Infarct (S-05) (Pg. 1153)

LAQ
(recent advances in treatment)
1. Stroke define, types; Acute* [Ischemic* (Thromboembolic) Stroke]* - management**; causes, c/f**;
-

etiopathogenesis (W-12) (W-11) (\W-08)(W-07) & risk factors

- RF
2. Cerebrovascular Accidents (part) (W-08)
3. Subarachnoid Haemorrhage* - c/t*, investigations, management*; causes (S-06)(W-02) (Pg. 1160)
- causes,
4. Acute Cerebral Embolism c/f, management (S-04)
5. Acute Focal Stroke define; Stroke - RE; Completed Stroke due to Cerebral Infarction - management
-

(W-03)
6. Circle of Willis - diagram (W-02)
 Psychiatry
SAQ

1. Anorexia Nervosa**** (W-19)(W-18)(W-16)(S-12)(W-05) (Pg. 1203)

2. Schizophrenia*** - c/f, management (S-19)(W-14)(S-12)(W-02) (Pg. 1196)
3. Anxiety Disorders - somatic symptoms;Anxiety Neurosis* (S-18)(S-11) (W-08)(S-08) (Pg. 1186)
4. Hypochondriasis (W-17) (Pg. 1202)
5. Bipolar Disorder* (S-17)(S-06) (Pg. 1199)Etiology, c/f, complications, management
6. Major Depression*; Chronic Depression; Manic Depressive Psychosis; Depressive Disorders - c/f;
symptoms, drug management (S-16)(S-13)(W-09)(W-07)(S-03) (Pg. 1198)
7. Phobias* (W-15)(S-04) (Pg. 1200)
8. Electroconvulsive Therapy***** - indications (S-15) (S-14) (W-10)(S-09)(W-06)(W-03) (Pg. 1190)
9. Schizophrenic Paranoid (S-15) (Pg. 1196)
10. Panic Disorders (S-13) (Pg. 1200)
*11. Obsessive Compulsive Disorder (W-11) (Pg. 1201)
12. Alcohol Dependence (S-10) (Pg. 1194)
13. Insomnia (S-08)
14. Wernicke-Korsakoff Syndrome (S-07) (Pg. 1195)
15. Selective Serotonin Reuptake Inhibitors (SSRI)(S-07) (Pg. 1199)
16. Hysteria (W-05)(W-04)
17. Hysterical Conversion Reactions (S-05)
18. Dissociative Disorder - define, management (S-03)
19. Bulimia Nervosa (W-02) (Pg. 1204)

LAQ

1. What is Thiamine; Wernicke's Encephalopathy and Korsakoff's Psychosis - describe, management

(W-06)

Dermatology
SAQ

-
Scabies*** treatment (S-20)(S-16)(W-08)(W-03) (Pg. 1241)
1.
2. Pemphigus Vulgaris (W-19) (Pg. 1256) (clinical characteristics of diff types)

**3. 4. Psoriasis*****PES- c/f; management (S-19)(S-18) (\W-16)(S-13)(W-09)(S-06)(W-05)(S-03) (Pg. 1247)

Stevens Johnson Syndrome* (W-17)(S-14)(W-12)(W-10)(5-03)
5. Lichen Planus (S-15) (Pg. 1252)
6. Acne Vulgaris* (w-14)(S-14) (Pg. 1241)
7. Genital Warts (S-12) (Pg. 342, 1238)
8. Taenia Corporis (S-11) (Pg. 1240)
9. Ring Worm (S-08) (Pg. 1239)
10. Tuberous Sclerosis (W-06) (Pg. 1264)
11. Pityriasis Rosea (W-06) (Pg. 1251)
12. Bullous Skin Lesions (W-04) (Pg. 1254)
13. Molluscum Contagiosum (W-03) (Pg. 1239, 343)
 14. Eczema - classification; Atopic Eczema - diagnostic criteria (W-03)
15. Nail in Systemic and in some common Skin Diseases (W-02) (Pg. 1260)

Clinical Immunology

SAQ

1. Anaphylaxis (S-19) (Pg. 75)

Poisoning
SAQ

1. OP Poisoning*** -
c/f*; treatment/management (S-20)(W-12)(S-10)(W-08) (Pg. 145)
2. Methyl Alcohol Poisoning (W-18) (Pg. 147)
3. Zinc Phosphide Poisoning (S-17) (Pg. 148)
4. Fluorosis* (S-11)(S-09) (Pg. 149)

Evenomation
SAQ

1. Neuroparalytic Snake Bite* - treatment* (W-18)(W-17) (Pg. 159)

Acute Medicine and Critical Illness

SAQ

1. Acute Respiratory Distress Syndrome (S-17) (Pg. 198)

Infectious Diseases
SAQ

1. Newer Drugs in Leprosy (W-19) (Pg. 269) (clinical characteristics of types)

Leprosy*** - classificationc/f; drug treatment; complications (S-18J6-17)|S-09)(S-04) (Pg. 267)
X*2. 3.
Lepra Reaction**** - types, management (W-17)(W-11) (W-07)(S-07)(W-05) (Pg. 268)
4. Lepromatous Leprosy** - c/f (S-14)(W-12)(W-09) (Pg. 267)
5. Chicken Pox (S-12) (Pg. 238)
6. Herpes Zoster*** (S-12) (S-07)(S-06)(S-04) (Pg. 239)
7. Chloroquine Resistant Malaria (S-11)
 8. Amoebiasis (W-08) (Pg. 286)

LAQ

-
1. Cerebral Malaria c/f, investigations, treatment,complications (S-17) (Pg. 275)

HIV Infection and AIDS

SAQ

1. Opportunistic Infections* in AlDS/HIV (S-18)(S-09) (Pg. 313)

Sexually Transmitted Infections

SAQ

Meningovascular Syphilis (S-17) (Pg. 337)

1.
2. Chancre (W-15) (Pg. 333)
3. Gonorrhea* (W-12)(W-09) (Pg. 339)
4. Genital Warts* (S-12)(W-06) (Pg.342, 1238)
-
5. Non-Gonococcal Urethritis* causes, drug management (W-11)(W-03) (Pg. 333)
6. Ulcerative Lesion on Penis/Penile Ulcer (S-11)(W-04) (Pg. 333)
7. Gonococcal Urethritis (S-08) (Pg. 333)
8. Sore on Penis - D/D (S-07)
9. VDRL (S-05) (Pg. 338)

Clinical Biochemistry and Metabolic Medicine

SAQ

1. SIADH (S-19) (Pg. 357)

2. Loop Diuretics (S-13) (Pg. 354)
3. Hyperkalemia* - management (S-12)(W-05) (Pg. 362)
4. Hypokalemia (W-07) (Pg. 361)
5. Role of Kidney in Water Balance (W-04) (Pg. 355)
6. Respiratory Acidosis (W-04) (Pg. 367)
7. Metabolic Acidosis (S-04) (Pg. 364)

TCardiology
LAQ

1. Marfan's Syndrome (S-20) (Pg. 508)

 2. Chronic Cor Pulmonale -etiopathogenesis, c/t, management (S-13)

Nutritional Factors in Disease

SAQ Balanced diet Eating disorders

1. Central Obesity (S-20)(S-10)

2. Niacin (S-19) (Pg. 714)
3. Wernicke's Encephalopathy (S-19) (Pg. 714)
4. Vitamin B3 (Pg. 714)
5. Bariatric Surgery - indications (S-16) (Pg. 703)
6. Anthropometry (BMI) (W-15) (Pg. 693)
7. Biotin (W-15) (Pg. 715)
8. Thiamine Deficiency* - c/f (S-15) (W-05) (Pg. 714)
9. Total Parenteral Nutrition** (S-15)(S-06)(W-04) (Pg. 707)
10. Vitamin C (W-14) (Pg. 715)
11. Pellagra******** (S-14)(W-13) (S-10)(W-09)(S-09)(S-08)(S-06)(S-05)(S-03) (Pg. 714)
12. Obesity**** - complications**; investigations (S-14)(W-12)(W-09)(W-07)(S-05) (Pg. 698)
13. Scurvy (W-11) (Pg. 715)
14. Beri Beri (S-11) (Pg. 714)
15. Hypervitaminosis A (S-11) (Pg. 713)
16. Vitamin E (W-08) (Pg. 713)
17. Zinc Deficiency (W-06) (Pg. 717)
18. UNICEF's Inexpensive Measures to Prevent Protein Energy Malnutrition (W-06)
19. Hypervitaminosis (S-04)

LAQ

1. What is Thiamine; Wernicke's Encephalopathy and Korsakoff's Psychosis - describe, management

(W-06)

Endocrinology
SAQ

1. Hypocalcemia** (S-17)(S-15)(W-08) (Pg. 662)

2. Pituitary Gland Hormones - enumerate (W-13)
3. Myxoedematous Coma (S-13) (Pg. 641)
4. Thyrotoxicosis - eye signs (W-10) (Pg. 636)
5. Addison's Disease - c/f (W-08) (Pg.671)
6. Tetany (W-02)
Diabetes Mellitus
SAQ

1. Metabolic Syndrome*/Syndrome X (W-18)(S-07) (Pg. 730)

2. Autonomic Neuropathy (S-16) (Pg. 760)
3. Diabetic Nephropathy* (W-11)(S-10) (Pg. 757)
4. DM - diet (W-08)

LAQ

1. Type 2 Diabetes Mellitus - c/f, complications; Insulin Therapy - indications (S-20)

2. Diabetes Ketoacidosis* - etiopathogenesis, c/f, management* (S-13)(W-10) (Pg. 735)
3. DM -types, acute & chronic complications (W-10)

Hematology
SAQ

1. Iron Deficiency Anemia - treatment (S-12) (Pg. 941)

2. Vitamin B12 Deficiency (W-04) (Pg. 945)

Drugs
1. Newer Drugs in Leprosy (W-19) (Pg. 269)
2. Newer Anti-Epileptic Drugs (S-19) (Pg. 1102)
3. MDR TB*** - treatment**/drugs (S-19)(S-17)(W-04)(W-02) (Pg. 595)
4. Rituximab (W-18) (Pg. 1006)
5. Clindamycin (W-15)
6. Pyridostigmine (W-15) (Pg. 1143)
7. Methotrexate (W-14)
8. Loop Diuretics (S-13) (Pg. 354)
9. Gabapentin* (S-13) (S-05)
10. Oseltamivir (W-10) (Pg. 127)
11. Selective Serotonin Reuptake Inhibitors (SSRI)(S-07) (Pg. 1199)
12. Lithium (W-06)
-
13. Tuberculosis chemoprophylaxis (W-06)
14. Newer Anti-TB Drugs (S-05)
-
15. Systemic Corticosteroid Therapy s/e (W-03)
Untitled
SAQ Application of genetic engineering in medicine

1. Antioxidants (S-18)
*2.3. Stem Cell Therapy (W-17) (Pg. 914)
Renal Hormones (S-17)
4. Alcohol - toxicity on nervous system (S-17)
5. Down's Syndrome* - neurological features (W-16)(S-13)
6. Hypercarbia (S-16)
7. Electric Shock (W-15)
8. Neurodermatitis (W-15)
9. Bioterrorism (W-13) (Pg. 111)
10. Hyperpyrexia (S-11)
11. Polymerase Chain Reaction (W-10) (Pg. 53)
12. Oxygen Therapy (W-10)
13. Alcohol Withdrawal Delirium (S-07) (Pg. 1194, 183)
14. Lathyrism - define, stages, preventive measures (W-03)
15. Pickwickian Syndrome (S-03)
 MPMSU Paper I - section A- General principles of Surgery, Oncology, head, face, neck, Breast,
Endocrine Surgery,
Syllabus:
Section B- Trauma and Orthopedic surgery.

Paper II- Gastrointestinal Tract including colon rectum and anal canal, Liver, pancreas and
Surgery biliary tract, Spleen. Paediatric Surgery, Urology, Cardio thoracic surgery and Plastic surgery,
Dental surgery, Radiology and Radiotherapy, Anaesthesiology.

Wounds and Wound Healing

SAQ

1. Factors affecting* /delaying* Wound Healing (W-18) (W-12) (S-10)(S-04) (Pg. 7)

2. Normal Wound Healing - phases (S-18) (Pg. 6)
3. Crush Syndrome (W-13) (Pg. 11)
4. Keloid (S-11) (Pg. 12)
5. Scar & Keloid - differences* (W-08)(W-04) (Pg. 14)

LAQ

1. Wound Healing - stages, factors influencing (S-15) (Pg. 7)

- -
2/ Wounds classify; Wound Healing types, factors affecting (W-05)

Ulcer,

LAQ

1. Non-Healing Ulcer- etiology, c/f, management (S-14) (Pg. 16)

Infectious Diseases
SAQ

1. Surgical Site Infection (S-17) (Pg. 62)

2. Gas Gangrene*- c/f (W-12)(S-09) (Pg. 50)
3. Carbuncle* (5-12)(W-06) (Pg. 45)
4. HIV Infection - universal precautions (W-10) (Pg. 67)

LAQ

1. Gas Gangrene* of LL - etiology*, c/f, diagnosis, management*; pathology (W-16)(W-06) (Pg. 50)
2. Surgical Wound Infection - RF; Surgical Wound - methods and procedures to minimize Wound Sepsis
(W-02) (Pg. 63)
Swellings
SAQ

1. Dermoid Cyst** (W-19)(W-17)(W-06) (Pg. 72)

2. Lipoma* (S-08)(W-06) (Pg. 68)

Electrolyte and Nutrition

SAQ

Percutaneous Endoscopic Gastrostomy (S-16) (Pg. 97)

1.
2. TPN* - complications* (S-15)(S-14) (Pg. 98)
3. Assessment of NutritionalStatus (W-10)
4. Metabolic Alkalosis (S-10) (Pg. 90)
5. Hypokalemia (S-09) (Pg. 89)
6. Enteral Nutrition (W-03) (Pg. 96)
&
advantages

Shock
SAQ

1.Systemic Inflammatory Response Syndrome (SIRS) (W-18) (Pg. 111)

2. Hypovolumic Shock (S-17) (Pg. 106)
-
3. Septic Shock types (S-14)
4. Shock- define, types (W-05)

LAQ

-
D Shock***** define*****, classify**;pathophysiology; types**;c/f (part) (S-20)(W-18)(S-18)(W-06) (S
1.
06) (W-04)(S-03)
2. Septic Shock**-etiopathology/causes, c/f*, management** (S-20)(W-18)(W-09) (Pg. 107)
3. Severe Sepsis - supportive therapeutic options (S-18)
4. Hypovolumic Shock* - management*; c/f (W-06) (\W-04)
Causes

Haemorrhage and Blood Transfusion

SAQ

Disseminated Intravascular Coagulation (W-19) (Pg. 120)

1.
2. Blood Transfusion Reactions; Blood Transfusion**** - complications*** (W-18)(S-14)(5-12) (W-07)
(W-04)(W-03) (Pg. 118)
3. Blood Substitutes (W-17) (Pg. 119)
-
4. Haemostasis methods (S-15) (W-10)
 Shock pathophysiology &
5. Haemorrhage** -types**; Haemorrhagic Shock - treatment (S-07)(W-05)(W-02) (Pg. 113)
6. Methods to Control External Haemorrhage (W-05)

LAQ

1. Blood Transfusion* - indications*, complications*, Blood Components* - list* (W-08)(S-04)

-
2. Haemorrhagic Shock* classify; principles of treatment (part) (W-12)(S-06) (Pg. 115)

Burns
SAQ
First 24 hrs
1. Fluid Management in Burns (W-19) (Pg. 127)
2. 50% Burns Patient weighing 60 kg - fluid calculation (S-17)

LAQ

-
1. Burns***** classify*, types*; pathophysiology** (part) (Pg. 122) (S-19)(W-17)(S-16)(W-08) (W-07)
(S-07) 40%
2. 70% Deep Thermal Burns in 50 kg male patient-pathophysiology, management (S-19)
3. 30% Deep Burns - initial resuscitation, management (W-17)
4. 50% Superficial Thermal Burns -c/f, investigations, management (S-16)
5. 60% Burns in 50 kg adult male/female - early management; management upto 1 week (W-08)(S-03)
6. 15% Deep Burns in 35 y/o male - management (W-07)
7. 30% Burns - management (S-07)

Trauma
SAQ

1. Polytrauma (W-19) (Pg. 133)

ABCD in
2. Damage Control Surgery (S-18) (Pg. 136)

LAQ

1. Blunt TraumaAbdomen - mechanism, pathophysiology; 27 y/o - h/o injury to abdomen 1 hour back
due to turning turtle of auto rickshaw - BP = 90/60 mm Hg PR = 120/min - management (W-13)
-

2. Shock due to Blunt Trauma resulting in Liver Injury - management (W-12) (Pg. 149 SRB 5th Edition)
3. A man falls off train - brought to casualty in unconscious state - management (S-12)
4. Polytrauma - parameters of emergency assessment (part) (W-03)
Hand and Foot
SAQ

1. Collar Stud Abscess* (W-13) (S-10) (Pg. 150,432)

Arterial Diseases
SAQ

1. Raynaud's Phenomenon (Pg. 176) (S-20)

2. Acute Lower Limb lschemia due to Embolus in Femoral Artery -management (S-16) (Pg. 185)
3. Dry Gangrene (W-07) (Pg. 199)
4. Gangrene - causes; Wet & Dry Gangrene - difference (S-07)
Intermittent Claudication* define; Ischemic Lower Extremity - signs (S-06)(W-05) (Pg. 162)
-
5.

LAQ Diabetic foot: etiopath, c/f, management

1. Gangrene**- define**, causes; types* (part) (W-16)(W-15)(S-08) (Pg. 199)

-
Buerger's Disease/Thromboangitis Obliterans* (TAO) c/f*, investigations, treatment*; define,
investigate, treat a patient of TAO with Rest Pain (W-15)(W-14)(S-08) (Pg. 172)
3. Peripheral Arterial Diseases -causes; Dry & Wet Gangrene - differentiate; PAD with Forefoot Dry
Gangrene - management (W-12)

Vascular Lesions
SAQ

1. Hamartoma (W-06) (Pg. 213)

Venous Diseases
SAQ

1.Varicose Ulcer**; Venous Ulcer - management (S-16)(S-15)(W-14)(S-12) (Pg. 232)

2. Phlegmasia Cerulea Dolens (W-13) (Pg. 217)
-c/f*; management (W-11)(S-08)(W-07) (Pg. 216)
X3. Deep Vein Thrombosis**
4. Varicose Veins - Eintattests& their interpretation (W-03) (Pg. 223)
5. Brodie-Trendelenberg Test - describe, inference (W-02)

LAQ

SuperficialVenous System of Lower Limbs; Veins of LL* - surgical anatomy**; Varicose Veins*** of LL -

pathophysiology*, management***; c/f*; etiology (S-19) (S-11)(W-10) (S-09) (Pg. 215, 219)
 2. Venous Drainage of Lower Limb - surgical physiology; Long Saphenous Vein Varicosities
etiopathogenesis, c/f, management (S-10)
3. Leg Ulcers - causes; Varicose Ulcers - treatment (S-03) (Pg. 234)

Lymphatics
SAQ

1. Lymphoedema* - management (S-19)(S-14) (Pg. 241)

LAQ

Unilateral Limb Oedema causes; Filaria Limb - surgical management (S-13) (Pg. 242)
-
1.

Neoplasm
SAQ

1. Tumor Markers (W-11) (Pg. 274)

2. Carcinoma In Situ (S-04)

Skin Tumors
SAQ Basal cell carcinoma

1. Dermatofibrosarcoma Protuberans (W-16) (Pg. 279)

2. Marjolin's Ulcer* (W-09)(S-09) (Pg. 283)
3. Malignant Melanoma (W-06) (Pg. 287)

Amputations
SAQ

1. Below Knee Amputations (W-11) (Pg. 311)

Reconstruction
SAQ

1. Partial & FullThickness Skin Graft - distinguish (S-06) (Pg. 317)

Transplantation
SAQ

1. Immunosuppressive Agents (W-16) (Pg. 329)

Faciomaxillary Diseases
SAQ

-
1. Cleft Lip* & Cleft Palate classify (S-17)(S-14) (Pg. 339)

OralCavity

SAQ

1. Ca Tongue* - TNM Staging; c/f (W-19)(W-05) (Pg. 366)

2. Leukoplakia of Oral Mucosa (W-15) (Pg. 359)
3. Plunging [Ranula]* (W-14)(W-09) (Pg. 356)
4. Submucous Fibrosis (Oral) (S-11) (Pg.360)
5. Pre-Malignant Lesions of Oral Mucosa (S-06)
6. Oral Cancers - RF (W-02) (Pg. 364)

LAQ

- -
1. Carcinoma of Oral Cavity describe pre-cancerous conditions; Ca Anterior % Tongue c/f, management
(S-09)

Salivary Glands
SAQ

1. Warthin's Tumor* (S-19)(W-17) (Pg. 403)

2. Pleomorphic Adenoma*** (S-12)(S-10)(W-09)(w-07) (Pg. 401)
3. Benign Parotid Tumors (W-11)

LAQ

1. Parotid Gland - surgicalanatomy* (part) (Pg. 392) (S-20)(S-17)

2. Parotid Tumors*- etiopathology, classification*; Pleomorphic Adenoma* of Parotid Gland -
-
management* (Pg. 401); Carcinoma of Parotid Gland management (S-20)(S-17)(W-15)
3. Salivary Gland Tumors - classify (part) (Pg. 400) (W-15)
Neck
SAQ

1. BranchialCyst** & Branchial Fistula (S-20)(S-18)(W-09) (Pg. 419)

2. Thoracic Outlet Syndrome (S-18) (Pg. 427)
3. Modified Radical Neck Dissection (S-13) (Pg. 440)
4. Cystic Hygroma* - pathogenesis, treatment (S-11)(S-03) (Pg. 424)
5. Cervical Rib* (W-10)(W-07) (Pg. 416)
6. Cold Abscess* in Neck - management (S-07)(S-05) (Pg.434)
7. Tuberculous Lymphadenitis sequelae (S-04) (Pg. 431)
Management & cervical lymphadenopathy causes

Thyroid
SAQ

1. Hashimoto's Thyroiditis* (S-20)(W-14) (Pg.478)

2AThyroid Function Test (S-19) (Pg. 449)
Solitary Thyroid Nodule**- investigations (S-18)(S-11)(W-04) (Pg. 454) Causes and management
4. Lateral Aberrant Thyroid (W-17) (Pg. 448)
5. Thyrotoxicosis** - Eye Signs*; management (S-17)(W-15) (S-03) (Pg. 461)
6. Thyroid Surgery/Thyroidectomy - postoperative complications* (W-16) (S-07) (Pg. 483)
7. Thyroglossal Cyst**** & Thyroglossal Fistula - management (W-15)(S-15)(S-09)(W-08)(S-05) (Pg. 447)
8. Multinodular Goitre (W-13) (Pg. 451) Management
9. Goitre - classification (W-12) (Pg. 450)
10. DeQuervain's Thyroiditis (S-10) (Pg.478)
11. Thyroid - surgical anatomy (W-08) (Pg.443)
12. Thyroid Storm (S-04) (Pg. 483)

LAQ
(thyroid swellings classification)
1. Midline Neck Swelling - D/D; Graves' Disease* -
c/f*, management*; etiology, investigations (W-19)
(S-08) (Pg. 458)
Goitre* - classify; define (part) (W-18)(W-02)
3. Papillary Carcinoma of Thyroid* - etiology, c/f*, diagnosis, management*; Thyroid Gland
Neoplasm/Thyroid Malignancies - describe; classify*; Papillary & Follicular Carcinoma difference;
-

Differentiated ThyroidCarcinomas - c/f, management (W-18)(S-14)(W-09) (W-09)(S-04) (Pg. 450, 468)

4. Thyroid Gland - surgical anatomy; 60 y/o lady with Multinodular Goitre - investigation, management
(S-16) (Pg. 441, 451) Etiology, c/f
-
5. Thyrotoxicosis*** c/f**, treatment*; types, medical & surgical treatment*; define, causes,
investigations (S-12)(W-11)(S-06)(S-05) (Pg. 458)
6. Non-Toxic Multin odular Goitre* - pathogenesis*, c/f*, investigations*, complications* (W-05)(W-02)
 Parathyroids and Adrenals
SAQ

-
1. Multiple Endocrine Neoplasia II (MEN-11) (S-13) (Pg.496)
2. Hyperparathyroism - c/f (S-08) (Pg. 491)

Breast
SAQ Retro mammary abscess Paget's disease of breast

1. Cystosarcoma Phyllodes** - c/f, management (S-20)(S-09)(S-06) (Pg. 512)

2. Fibroadenoma* Breast (S-19)(S-16) (Pg. 508)
3. Carcinoma Breast*** - chemotherapy; routes of spread; etiological factors; methods of screening
(W-18)(W-08)(W-05)(W-02) (Pg. 546)
4. Nipple Discharge; Blood Stained Nipple Discharge - causes, investigations (W-16)(S-03) (Pg. 556)
5. Triple Test in Ca Breast (W-15) (Pg. 538)
6. Locally Advanced Breast Carcinoma* - management* (S-13)(S-07) (Pg. 548)
7. Giant Fibroadenoma (S-13)
8. Gynaecomastia (S-08) (Pg. 519)
9. Patey's Mastectomy - structures removed (W-05) (Pg. 538)
10. Inflammatory Carcinoma of Breast (W-04) (Pg. 525)

ALAQ
(stage 2) (stage 3) (&metastatic ca management)
Carcinoma Breast*** - c/f, management; predisposing factors, investigations; pathological types,
spread, role of conservative breast surgery; clinical staging (W-19)(W-14)(S-11)(W-10) (Pg. 522)
2. Breast** - surgical anatomy** with figures (part) (S-18)(S-10)(W-04)
3. Locally Advanced*** Carcinoma of Breast - management(S-18)(S-17)(W-13)(S-05) (Pg. 548)
4. Benign Breast Diseases** - classify; discuss; clinicalpresentations, management*;etiology,
pathogenesis, c/f (W-17)(W-14)(S-10)
5. Malignant Breast Tumors - classification, etiology (S-17)
6. Triple Assessment - define (part) (S-15)
S7.Early** Carcinoma of Breast** in 32 y/o lady -management** (S-15)(W-11)(W-1o)
8. Cancer Breast - current histopathological nomenclature, characteristic of each one (part) (W-13)
9. Operable Breast Cancer - define; T2N1M0 Breast Cancer - management (W-07)
10. Lymphatic Drainage of Breast (part) (S-05)
11. Carcinoma Breast Stage I|* - c/f, management* (W-04)(W-03)
12. 4 cm Lump in Upper-Outer Quadrant of Breast of 55 y/o female - D/D (W-03)
Ca breast classification & invasive ductal carcinoma: c/f & management

Neurosurgery
SAQ

1. Subdural Hematoma (S-19) (Pg. 1082)

 -
2. Modified [GlasgowComa Scale]***** significance* (W-18)(W-17)(W-15)(W-09) (S-05)(S-03) (Pg.
1079)
.
3. Extradural Hematoma**** diagnosis*,c/f**, investigations* (W-16)(W-08)(S-05)(W-04)(W-02) (Pg.
1081)
4. CT Scan for Head Injury (W-14) (Pg. 1077)
5. Lucid Interval (W-12) (Pg. 1081)
6. # Base of Skull- diagnosticsigns (S-08) (Pg. 1085)

LAQ

1. Head Injuries - classify; Subdural Hematoma - signs, symptoms, management (S-13) (Pg. 1082)
2. Head Injury - c/f, investigations, management (S-07)
3. Severe Head Injury - principles of initialmanagement (W-03)

Thorax
SAQ Tension pneumothorax Empyema thorax

1. Flail Chest***** (S-20)(S-16) (W-13)(S-12)(S-11)(S-05) (Pg. 1100)

Stomach Abdominal compartment syndrome

LAQ

-
1. Carcinoma Stomach etiology, c/f, diagnosis, management (W-16) (Pg. 835)
2. CHPS (W-12) (Pg. 811)

Large Intestine
SAQ

1. Targeted Chemotherapy for Colonic Malignancy (S-13) (Pg-899)

Scrotum
SAQ

1. Fournier's Gangrene (S-15) (Pg. 1056)

 Adjuvant Therapy
SAQ

1. Radiotherapy - complications (W-10) (Pg. 1127)

Anaesthesia
SAQ

1. Spinal Anesthesia (W-14) (Pg. 1136)

Operative Surgery
SAQ

1. Tracheostomy* - indications; complications (W-08)(W-03) (Pg. 1157)

TUntitled Diagnostic laparoscopy

SAQ Surgical audit

1. Antibiotic Prophylaxis (W-11)

2. Brainstem Death - clinical testing (S-06)
3. Name any three Pre-Malignant Conditions* (W-05)(W-02)
4. Cancer Screening Program - objectives, principles (W-03)
LB
Orthopedics Fracture ribs: c/f and management

1: Introduction

SAQ

1. Open Fracture - classification (S-10) (Pg. 2)

(Management)
LAQ

1. Fracture** - define**,classify**; radiological patterns (part) (S-18)(W-08)(W-05) (Pg. 1)

2: Anatomy of Bone and Fracture Healing

SAQ

1. Fracture Healing* (W-13)(W-04) (Pg. 10)

LAQ

1. Fracture Healing* intubular bone - stages, factors affecting (W-08)(W-05) (Pg. 11)

3: Treatment of Fractures: General Principles

SAQ Fracture of necessity
-
1. Compound Fracture/Open Fracture primary management (S-19)(S-09) (Pg. 21, 2)
2. Conservative Management of Fractures (W-11)
3. Rehabilitation - role in fracture treatment (S-05) (Pg. 19)

LAQ

1. Compound Fracture - principles of management (S-18) (Pg. 21)

4: Splints and Traction

SAQ

-
1. Tractions* in Orthopedics types, uses (W-19)(W-09) (Pg. 26)
2. Skeletal Traction (S-16) (Pg. 27)
3. Thomas Splint (W-15) (Pg. 25)
4. Skin Traction - uses, indications, contraindications (W-07)
 5. Commonly Used Splints and Tractions - enumerate (S-04)

5: Recent Advances in the Treatment of Fractures

SAQ

1. Interlocking Nail (S-12) (Pg. 32, 142)

2. Distraction Osteogenesis (S-09) (Pg. 34)

7: Complications of Fractures
SAQ Epiphyseal injuries: classification & management

1. Compartment Syndrome**** of forearm - causes, c/f*, treatment*; define (W-18)(S-18)(W-16)

(W-08)(S-06) (Pg. 47)
-
2. Sudeck's Osteodystrophy* of wrist & hand c/f, diagnosis, treatment (W-15) (W-08) (Pg. 51)
*3. Non-Union*******.- define*, types****, management*****; causes* (W-15)(W-14)(S-12)(W-09)
(W-06)(S-05)(S-03)(W-02) (Pg. 48)
4. Malunion of Fractures (S-13) (Pg. 49)
5. Fat Embolism (S-09) (Pg. 43)
6. Post-Traumatic Ossification - diagnosis, management (W-03) (Pg. 52)

9: Fractures in Children
SAQ

1. Physeal Injuries (S-16) (Pg. 58)

2. Greenstick Fracture (W-14) (Pg. 57, 109)

10: Peripheral Nerve Injuries

SAQ

1. Late Ulnar Nerve Palsy - management (Pg. 71) (S-20)

2. Radial Nerve Palsy/Injury** (5-17)(W-13) (S-11)(W-03) (Pg. 65)
3. Foot Drop - causes, c/f, treatment (W-16) (Pg. 63)
-
4. Nerve Injuries classify, management (W-15)
5. Neuropraxia* - define, causes, principles of treatment (S-08)(W-07) (Pg. 63)
6. Tinel's Sign (S-07) (Pg. 69)
 12: Treatment of Orthopedic Disorders: General Review
SAQ

1. Bone Graft and other Bone Substitutes (W-11) (Pg. 84)

13: Injuries Around the Shoulder, Fracture Humerus

SAQ

1. Anterior Dislocation of Shoulder** Joint - types, treatment, complications; signs (W-11) (W-08)(W-04)
(Pg. 90)

14: Injuries Around Elbow

SAQ Tardy nerve palsy

Cubitus Varus (S-19) (Pg. 102)

1. (VIC)

**2. Volkmann's Ischemic Contracture** (w-17)(W-12)(W-10) (Pg. 101)

3. Volkmann's Ischemia** - clinical diagnosis*, management**; c/f (W-15)(S-09)(W-03) (Pg. 101)

LAQ

-
1. Volkmann's Ischemic Contracture c/f, management (Pg. 101) (S-20)
-
Supracondylar Fracture Humerus**** in 7 y/o* child c/f**, management***, complications*;
mechanism of injury*; describe X-Ray*; conservative management; types, immediate complications
(S-14)(S-12)(S-08)(S-07)(S-03) (Pg. 97)

15: Injuries of the Forearm and Wrist

SAQ

1. Fracture Scaphoid** (W-17)(W-12) (W-10) (Pg. 115)

2. Colles' Fracture****** - complications**
****;define* (W-13)(W-12)(W-10)(S-09)(W-08)(W-04)(W-02)
(Pg. 111)
3. Monteggia Fracture Dislocation* - describe, management; define, c/f, mode of injury (S-11)(W-07) (Pg.
110)
4. Smith's Fracture - mechanism of injury, displacement (S-07) (Pg. 114)
5. Enumerate Injuries occurring due to Fall on Outstretched Hand (W-02)

LAQ

1. Colles' Fracture** - define*, c/f**, classification, management**,complications** (W-18)(W-15)(S-04)

(Pg. 111)
 -
2. Lower End of Radius* enumerate fractures* (part) (W-15)(S-04)

16: Hand Injuries

SAQ

1. Mallet Finger (S-07) (Pg. 118)

17: Pelvic Fractures

SAQ

1. Fracture Pelvis** - complications*; principles of treatment of visceral complications (W-09)(S-08)

(W-05) (Pg. 127)

18: Injuries Around the Hip

SAQ

1. Intracapsular [Fracture Neck Femur]***** - management*; complications*; classify* (S-20)(W-19)(S

10)(W-09)(S-06)(S-03) (Pg. 132)
2. Femoral Head - blood supply (W-19) (Pg. 129)
3. Hip Dislocation (W-19) (Pg. 130)

LAQ

1. Intertrochanteric Fracture* Femur (in elderly) - mechanism of injury, c/f*, management*; classification
(W-17)(S-13) (Pg. 138)
2. Fracture Neck Femur* - classify*, c/f*, management* at various ages; X-Ray findings (S-15)(S-09) (Pg.
132) (geriatric)
3. Posterior Dislocation of Hip - mechanism of injury, clinico-radiological features, management (W-03)
(Pg. 130)

19: Fracture Shaft of Femur

SAQ

-
1. Fracture Shaft Femur in adults management (S-10) (Pg. 141)
20: Injuries Around the Knee
SAQ

1. Patella Fracture** -types, surgical treatment (S-17)(S-15) (S-14) (Pg. 146)

LAQ

1. Fracture Patella - c/f, investigations, treatment (W-10) (Pg. 146)

21: Injuries to Leg, Ankle and Foot

SAQ

1. Pott's Fracture* -classification*, management (S-11)(W-02) (Pg. 159)

2. Ankle Sprain (S-08) (Pg. 163)

LAQ

-
1. Pott's Fracture* in adults classification*,clinico-radiological features, management*; mechanism of
injury (S-17)(W-14) (Pg. 159)
2. Fractures of Shaft of Tibia - types, investigations,treatment; Closed Interlocked Intermedullary Nailing -
advantages (S-06) (Pg. 155)

22: Infections of Bones and Joints

SAQ

1. Acute Osteomyelitis***** in child - c/f**; management; pathogenesis; define, types (S-20)(W-17)(S

15)(S-11)(S-10)(W-02) (Pg. 168)
2. Chronic Osteomyelitis****** - radiological signs/features*; management; complications*; c/f*
(W-19)(S-17)(S-16) (W-15)(W-14)(W-13)(S-03) (Pg. 173)
3. Brodie's Abscess (S-19) (Pg. 175)
4. Sequestrum* -types (S-14)(S-06) (Pg. 172)
5. Pyogenic Infection of Knee Joint - c/f, investigations, principles of treatment (W-07)

LAQ

Chronic Osteomyelitis* - pathogenesis, c/*, principles of treatment/management, complications;

etiopathology, radiological features (W-16)(W-09) (Pg. 173)
2. Acute Osteomyelitis** - define, etiopathology**,c/f**, treatment; radiological features,
management*; investigations (W-07)(S-05)(W-04) (Pg. 168)
23: Tuberculosis of Bones and Joints
SAQ
Pathophysiology of osteoarticular TB &

-
1. Pott's Spine/Tuberculosis of Spine* investigations; c/f*, radiological signs/features (S-20)(S-06) (S-03)
(Pg. 185)
-
(2. Tuberculosis of Hip****** Joint stages**; c/f*, management* (W-18) (W-16)(S-15) (S-13) (VW-12)

(W-10)(W-06) (Pg. 194)

3. Tubercular Dactylitis (S-18) (Pg. 203)
4. Pott's Paraplegia* of Late Onset; Early Onset - causes, prognosis (S-07)(W-05) (Pg. 191)

LAQ

1. Koch's Spine; Tuberculosis of Spine*Nat Dorsolumbar Spine*/at Vertebral Level D12 with Incomplete
Paraplegia; Pott's Spine* - c/f* *****, management******; pathology*, radiological features*;
etiopathology; investigations; etiology, pathogenesis* (S-16)(W-13)(W-12) (S-11) (S-10)(W-02) (Pg. 185)

25: Congenital Talipes Equino Varus (CTEV)

SAQ Ponseti technique

1. CTEV******/Clubfoot** in child of 2 years - treatment; management****; treatment protocol from

birth upto 1 year; conservative management; differentiate between extrinsic and intrinsic type (S
20)(W-17)(S-16)(S-14)(W-12)(W-10)(S-08)(\W-05)(S-04) (Pg. 214)

26: Congenital Dislocation of Hip and Other Malformations

SAQ Developmental dysplasia of hip

1. Ortolani's Test for CDH - describe (S-07) (Pg. 221)

2. Congenital Dislocation of Hip (CDH) in an infant - c/f (S-05) (Pg. 220)

27: Poliomyelitis and Other Neuromuscular Disorders

SAQ

1. Poliomyelitis - stages (W-04) (Pg. 227)

28: Bone Tumors
SAQ

1. Chondrosarcoma* (W-19) (S-11) (Pg. 246)

2. Ewing's Sarcoma** (S-19)(S-17)(S-15) (Pg. 243)
3. Osteochondroma***** - clinico-radiological features, treatment; c/f, complications, management
(W-18)(S-16)(W-13)(S-08)(W-07)(w-03) (Pg. 247) Etiopath,c/f, management
4. Osteogenic Sarcoma/Osteosarcoma- radiological features* (S-18)(S-10) (Pg. 240)
-
5. Giant Cell Tumour*******/Osteoclastoma sites*, radiological features*, treatment**; c/f**;
management*; define,types (W-17)(W-16)(W-12) (S-12)(W-10)(S-09)(W-08)(W-06) (\W-02) (Pg. 237)
6. Aneurysmal Bone Cyst (W-14) (Pg. 249)
7. Osteoid Osteoma* (S-14)(S-13) (Pg. 235)
8. Unicameral Bone Cyst (S-06) (Pg. 248)
9. Skeletal Metastasis - primary sites; What is Occult Primary; Bone Metastasis - common locations
(W-05) (Pg. 246)
10. Benign and Malignant Bone Tumors* -clinical differences* (S-05)(S-03)

29: Prolapsed Intervertebral Disc

SAQ

1. Prolapsed Intervertebral Disc* (S-13)(S-12) (Pg. 252)

32: Traumatic Paraplegia

SAQ

-
1. Paraplegia in # Spine management (W-06) (Pg. 276)
2. Traumatic Paraplegia - principles of management (S-04) (Pg. 276)

33: Scoliosis and Other Spinal Deformities

SAQ

1. Milwaukee Brace (W-18) (Pg. 282)

34: Arthritis and Related Diseases

SAQ

1. Ankylosing Spondylitis* (W-18)(W-14) (Pg. 290)

 -
2. Rheumatoid Arthritis of hand treatment (S-04) (Pg. 289)

35: Degenerative Disorders

SAQ

1. Osteoarthritis of Knee***** - c/f*, management; radiological findings*, principles of treatment (S

15)(S-13)(S-12)(W-09)(W-05)(W-04) (Pg. 295)
2. Degenerative Arthritis/Osteoarthritis and Rheumatoid Arthritis*- differences* (S-05)(S-03) (Pg. 300)

LAQ

1. Osteoarthritis of Knee Joint - etiopathogenesis, c/f, investigations, treatment (W-06) (Pg. 295)

36: Affections of Soft Tissue

SAQ

1. Tennis Elbow**** - define*, causes*, treatment* (W-16)(S-16) (S-12)(W-09)(W-04) (Pg. 302)

2. Golfer's Elbow (S-14) (Pg. 302) (adhesive capsulitis)
t3. Frozen Shoulder* - define, c/f, principles of treatment (W-13)(W-07) (Pg. 304)
4. DeQuervain's Tenisynovitis (W-11) (Pg. 303)
5. Plantar Fascitis (S-08)(Pg.304)
6. Carpal Tunnel Syndrome (S-06) (Pg. 303)
7. Ganglion (S-04) (Pg. 303)

37: MetabolicBone Diseases

SAQ

1. Osteomalacia (S-19) (Pg. 312)

2. Rickets***** - c/f**; radiological features; describe X-Ray; management* (S-18)(S-15)(W-14)(S-07)
(W-06)(W-03) (Pg. 310)
3. Osteoporosis* - causes, fractures due to osteoporosis (S-17)(W-05)(Pg. 308)
4. Deficiency Rickets; Nutritional Rickets (S-13)(S-04) (Pg. 310)
5. Osteoporosis and Osteomalacia - difference (part) (W-05)

LAQ

1. Rickets - define, classification, pathophysiology, c/f, management (W-19) (Pg. 310)

38: Miscellaneous Affections of the Bone
SAQ

1. Avascular Necrosis of Femoral Head (Pg. 318) (S-20)

2. Perthes' Disease (W-18) (Pg. 318)
3. Osteogenesis Imperfecta (S-18) (Pg. 316)

LAQ

1. Perthes' Disease - signs, symptoms, radiological changes, management, complications (W-19) (Pg. 318)

39: Miscellaneous Regional Diseases

SAQ

1. Congenital Vertical Talus (S-17) (Pg. 326)

2. Genu Valgum and Genu Varum (S-11) (Pg. 324)

40: Amputations, Prosthetics and Orthotics

SAQ

1. Modern Day Amputation Prosthetics (S-19) (Pg. 331)

2. Amputation* - define, indications*, types*, complications (W-16)(W-02) (Pg. 332)

41: Arthroscopic Surgery

SAQ

1. Arthroscopy in Knee (W-06) (Pg. 334, 152)

42: Joint Replacement Surgery

SAQ

1. Total Hip Replacement (W-11)(Pg. 339)

43: Imaging Modalities in Orthopedics
SAQ

1. MRIin Orthopedics (S-14) (Pg. 342)

Annexure
SAQ

1. Thomas' Test for Hip (W-03) (Pg. 349)

Untitled
SAQ

1. TT Splint (S-18)
2. Tourniquet (W-17)
3. Human Cartilage - micro-anatomy (W-11)
4. Bone Substitutes (W-11)
5. Wallerian Degeneration (S-10)
6. Bony Swelling in Upper End of Tibia in adult - D/D (W-09) (Pg. 359, 366)
-
7. Displaced Fracture diagnostic examination findings (S-05) (Pg. 98?)
 Surgery - I|

GIT

Peritoneum
SAQ

1. Mesenteric Cyst** (S-20)(S-16)(S-13) (Pg. 569)

LAQ

-
1. Perforation Peritonitis etiology, c/f, management (W-04)

Abdominal Tuberculosis
SAQ

1. lleocaecal Tuberculosis (W-17) (Pg. 574)

2. Koch's Abdomen - c/f (W-03) (Pg. 574)

LAQ

1. lleocaecal Tuberculosis - c/f, investigations, treatment (W-13) (Pg. 574)

2. Abdominal Tuberculosis - c/f, investigations,treatment (W-11) (Pg. 573)
Tuberculosis -
Intestinal c/f, investigations,treatment (S-04)

Liver
SAQ

1. Budd Chiari Syndrome (W-18) (Pg. 619)

2. Amoebic Liver Abscess *** (S-16) (W-13)(S-12)(W-08) (Pg. 589)
3. Hydatid Cyst in Liver** - management;causative parasites, layers (S-15)(W-09)(S-03) (Pg. 595)
4. Surgical Jaundice - causes (W-13) (Pg. 646)
5. Liver Abscess - management (S-13) (Pg. 591)
6. OesophagealVarices** - methods of controlling*; Acute Oesophageal Variceal Bleeding - emergency
management (S-12) (S-10)(5-05)(W-03) (Pg. 610)
7. Echinococcus Granulosus -life cycle (S-07)
LAQ

1. Chronic alcoholic patient comes to casualty with haematemesis - Bleeding Oesophageal Varices -
investigation, management (Pg. 611) (S-20)
2. Echinococcus Granulosus - life cycle; Liver Hydatid Cyst* - C/F*, management*, complications*
(W-19)(S-17) (Pg. 595)
3. Solitary Lesion in Liver - D/D; 50 y/o shepherd - right hypochondriac lump - investigations,
management (S-14)
4. Liver - surgical anatomy including Couniaud's Segments; Liver Tumors - classify; Malignancy of Liver -
management (W-11) (Pg. 584, 599)
- -
5. Amoebic Liver Abscess* etiology*, c/f*, management*; Abscesses in Liver causes (S-11)(S-07)(Pg.
589)
-
6. Massive Haematemesis in Shock due to Oesophageal Varices management (W-10) (Pg. 612)
-
7. Bleeding OesophagealVarices c/f, investigations, treatment (W-06)
- causes; -
8. Portal Hypertension Hepatic Pre-Coma c/f, investigations, treatment (S-06) (Pg. 607, 620)
Etiopath and c/f)

Gallbladder
SAQ

-
1. Choledocholithiasis*/Biliary Stones/Common Bile Duct Stones management* (S-20)(S-18)(W-16)(S
08) (Pg. 642)
2. Gall Stone lleus - c/f, management (S-19) (Pg. 640)
3. ERCP* (Endoscopic Retrograde Cholangiopancreaticography) (W-14)(S-10) (Pg. 625)
4. Choledochal Cyst** - define, types (only diagrams) (W-14)(S-13)(S-06) (Pg. 628)
5. Cholelithiasis* - etiopathology (S-14)(S-11) (Pg. 631)
6. T-Tube Cholangiography (W-13) (Pg. 627)
7. Extrahepatic Biliary Atresia (W-13) (Pg. 630)
8. Clay Coloured Stools (W-12)
9. Graham-Cole Test (W-09)
10. Gallstones*** - complications**; types; Jaundice - preoperative preparation (W-09)(S-09)(S-07)(S-06)
11. Obstructive Jaundice - investigations (W-08) (Pg. 646)
12. Intra-operative Cholangiogram while performing Cholecystectomy - indications (S-06)
13. Empyema Gallbladder (W-05) (Pg. 638)
14. Ultrasonography in Cholecystitis (Acute & Chronic) (W-02)
Management of Pt with S. Bilirubin 15
LAQ (direct 11, indirect 4) & SAP 200iu)

1. Obstructive Jaundice**/Surgical Jaundice**- define; causes*****, investigations**; Obstructive

Jaundice due to Common Bile Duct Stones - management; Common Bile Duct Calculi** - treatment**,
1 cm Calculus in Common Bile Duct - management; Choledocholithiasis - management (W-17)
(W-14)(W-12)(S-10)(S-05)(S-04)(S-03) (Pg. 646, 642)
2. Gallstones*** - pathophysiology; etiopathology, c/f, complications**, management; causes,effects
(W-15)(W-10)(W-12)(W-07)
3. Acute Calculous Cholecystitis*** in 60 y/o Diabetic -management***; c/f**; etiopathology,
complications (W-15)(S-15)(S-12)(W-07) (Pg. 635)
4. Congenital Anomalies of Biliary Tree - enumerate; Choledochal Cyst - management (W-03)
Spleen
SAQ Splenic trauma

N1.Elective [Splenectomy******} - indications****; complications*; Blood Disorders treated by

Splenectomy (W-17) (\W-16)(S-16)(W-07)(W-06)(W-04)(S-04)(S-03) (Pg. 668, 669)
-
2 Splenomegaly causes (S-14) (Pg. 665)
-
3. Spleen surgical anatomy (W-09) (Pg. 660)
4. Splenic Injuries - c/t, management (S-05)

LAQ

-
1. Splenic Rupture c/t, investigations, management (S-08) (Pg. 661)

Pancreas
SAQ Annular pancreas

Acute Pancreatitis**** - complications***;etiology (W-19)(S-17) (W-11)(W-08)(W-05) (Pg. 681)

1.
2. Pseudocyst of Pancreas******** - management** (W-18)(S-18)(\W-17)(W-15)(W-12) (S-11)(S-09)
(S-08)(S-05) (Pg. 682)
3. Insulinoma (S-14) (Pg. 702)
4. Zollinger-Ellison Syndrome (W-10) (Pg. 704)

LAQ

-
Obstructive Jaundice due to Ca Head of Pancreas c/f, investigations, management (W-18) (Pg. 695)
1.
2. 35 y/o male chronic alcoholic acute onset upper abdominal pain and vomiting - ultrasound
- -

examination shows bulky, edematous Pancreas - management (S-15) (Pg.675)

Acute Pancreatitis*** - etiopathogenesis*, management*; c/f, complications; causes*; Mild& Severe
Pancreatitis - differentiate (W-14)(W-09)(W-04)(W-02) (Pg. 675)
4. Chronic Pancreatitis - etiology, RF, investigations, c/f, treatment (S-13) (Pg. 685)
5. Pseudocyst of Pancreas* -management* (part) (W-04)(W-02)
Pathogenesis,c/f & diagnosis

Abdominal Walland Umbilicus

SAQ

-
Vitellointestinal Duct** anomalies*; developmental anomalies (W-19)(5-17) (S-10) (Pg. 730)
1.
2. Omphalocele (W-18) (Pg. 735)
3. Umbilical Granuloma (W-15) (Pg. 729)
4. Congenital Anomalies of the Umbilicus - enumerate (S-03)
Hernia
SAQ Hernia en glissade

1. Femoral Hernia (S-18) (Pg. 763)

2. Congenital Diaphragmatic Hernia (W-16)
3. Epigastric Hernia* (S-16)(S-09) (Pg. 771)
4. Obstructed Inguinal Hernia - c/f (S-15)
5. Congenital Hernia (S-09)
6. Strangulated Hernia* - c/f, management*; difference from routine treatment of Hernia (S-08)(W-02)
7. Inguinal Defence Mechanisms for Prevention of Hernia (S-07) (Pg. 744)
8. Richter's Hernia* (W-06)(W-04) (Pg. 773)
9. Internal Ring Occlusion Test in Inguinal Hernia - describe, enumerate pitfalls of false positive test (S-06)
(Pg. 747)
10. Incisional Hernia - factors leading to formation, types of repair (S-06)
11. Paraumbilical Hernia in adult - c/f, treatment (W-02) (Pg. 770)

LAQ Mesh repair for inguinal hernia

Anterior Abdominal Wall- anatomy; Incisional Hernia methods of repair (W-18) (Pg. 768)
-
1.
1. Inguinal Canal- surgical anatomy; Inguinal Hernia - etiology, types, c/f; Strangulated Inguinal Hernia -

management (W-07) (Pg. 743, 740, 761)

Oesophagus
SAQ

1. Achalasia Cardia**** - treatment modalities (S-20)(W-18) (W-17)(W-09)(S-06) (Pg. 788)

-
2. Carcinoma Oesophagus management (S-19) (Pg. 795)
3. T.O. Fistula* -management in adult; Congenital Tracheo-Oesophageal Fistula - types (S-19)(S-09)(S-04)
(Pg. 793)
4. Mallory-Weiss Syndrome - investigations, management (S-19) (Pg. 743)
5. Oesophageal Atresia (W-06)
6. Dysphagia* - oesophageal [causes]* (part) (S-06)(S-04)

LAQ

1. Oesophagus* - surgical anatomy* (part) (S-16)(S-08) (Pg. 776)

2. Achalasia Cardia - c/f, management (S-16) (Pg. 788)
3. Dysphagia *** - causes**; D/D in 65 y/o man (part) (W-13) (W-08)(S-08)(S-07) (Pg. 778)
4. Carcinoma Oesophagus** involving Lower Third* - c/f**, management***; investigations; etiology
(W-13)(W-08)(S-08)(S-07)
Stomach
SAQ Early gastric cancer

1. Flexible GI Scopy* (W-19)(S-17) (Pg. 808)

2. H. Pylori (W-17) (Pg. 810)
3. Congenital/Infantile Hypertrophic Pyloric Stenosis *** -c/f*, surgical treatment; treatment (W-14)
(W-11)(S-04)(W-02) (Pg. 811)
4. Perforated Peptic Ulcer -treatment (S-12) (Pg. 823)
5. Lymphatic Drainage of Stomach - diagram (W-11) (Pg. 806)
6. Bleeding Peptic Ulcer - management (S-11) (Pg. 824)
7. Zollinger-Ellison Syndrome (W-10) (Pg. 704)
8. Peptic Ulcer Surgery* - sequelae* (W-10)(S-10) (Pg. 828)
9. Trichobezoar (W-07) (Pg. 831)
10. Peptic Ulceration - complications (W-06) (Pg. 815, 816)
11. Carcinoma Stomach** - investigations; RF, investigations;surgical treatment (W-05)(S-05)(W-03) (Pg.
842)
12. Haematemesis* -causes* (W-04)(W-02) (Pg. 827)
13. Gastrojejunostomy - late complications (W-03) (Pg. 850)
14. Chronic Duodenal Ulcer - complications, operations to treat the complications (S-03)

LAQ

1. Carcinoma Stomach*** in 50 y/o Alcoholic Male Patient; involving Antrum - etiopath ology, c/f*,
management***; etiopathogenesis*, staging; investigations* (W-17)(W-16)(S-14)(S-10) (Pg. 835)
2. Gastric Outlet Obstruction - causes (part) (S-14) C/f, investigations & management
3. Haematemesis* - causes* (part) (W-10)(W-06) (Pg. 827)
4. Stomach - anatomy, blood supply, lymphatic drainage (part) (S-10)
5. Chronic Peptic Ulcer* - complications*; Perforated Duodenal/Peptic Ulcer- pathology", c/f*,
management* (S-09)(W-05) (Pg. 821)

Small Intestine
SAQ

1. Meckel's Diverticulum****** (S-18)(W-15)(S-12) (S-11)(W-08)(W-07)(S-07) (Pg. 853)

2. Surgical Complications of Typhoid (S-08) (Pg. 858)

Large Intestine
SAQ

1. Diverticulitis (Pg. 880) (S-20)

2. Colostomy* (W-14)(W-12) (Pg. 901)
3. Amoeboma (W-14)
 4. Hirschsprung Disease (S-14) (Pg. 877)
5. Carcinoembryonic Antigen (W-12) (Pg. 897)
-
6. Carcinoma Colon screening tests (S-11) (Pg. 896)

LAQ

1. Colon Cancer/Tumors - etiopathology; classification (part) (W-19)(W-05) (Pg. 892)

2. Ulcerative Colitis - etiology, pathology, c/f, management (S-16) (Pg. 883)
3. Sigmoid Colon Carcinoma - pathology, c/tf, management (S-12) (Pg. 892)
4. Carcinoma of Caecum* - pathology*, c/f*, management*; etiology (S-11)(W-09) (Pg. 892)
5. Mass in Right lliac Fossa - causes (part) (W-09)
6. Carcinoma (Rt) Colon*- pathology*, c/f*, investigations; treatment (W-05)(W-02)

IntestinalObstruction
SAQ

1. Acute [Intussusception]** (W-19)(S-17)(\W-09) (Pg. 919)

2. Sigmoid Volvulus* (W-17)(W-10) (Pg. 922)
3. Volvulus (W-13) (Pg. 922)
4. Acute Intestinal Obstruction - radiological features (S-10) (Pg. 912)

LAQ

1. Small BowelObstruction - causes; Intussusception in Children - investigations, management (S-19) (Pg.

908, 919)
2. Intestinal Obstruction*** causes**;pathophysiology (part) (W-13)(W-11)(W-08)(S-06) (Pg. 908)
3. 60 y/o known case of Appendicular Abscess 10 years back - h/o 5 episodes of vomiting, abdominal
distension, obstipation since 3 days - PR= 90/min - BP = 100/60 mm Hg X-Ray showed Multiple Air
-

Fluid Levels - diagnosis, management (S-13)

4. Sigmoid Volvulus -c/f, investigations, management (W-08)
5. Obstruction due to Volvulus of Small Intestine - pathophysiology, treatment (S-06)
-
6. Acute Intussusception* in an infant/child c/f*, management*;etiopathology (S-05) (S-03)

Appendix
SAQ

-
1. Appendicular Carcinoid management (S-19) (Pg. 939)
2. Acute* [Appendicitis]* - c/f"; D/D (W-16)(S-15)(W-10) (Pg. 930)
3. Appendicular Mass/Lump (S-14)(W-06) (Pg. 937)
4. Appendicular Abscess**- treatment (W-05)(W-04)(S-04) (Pg. 937)
C/f, diagnosis
LAQ Oschner sherren's regimen

1. 20 year old male - fever, vomiting, pain in abdomen since one week - lump in right iliac fossa on clinical
examination - investigations, management of Appendicular Lump (S-18) (Pg. 937)
Acute Appendicitis - etiopathogenesis, c/f, management (S-16) (Pg. 929)
3. 25 y/o married woman - sudden onset pain in right iliac fossa - causes, c/f, relevant investigations,
treatment (W-06)

Rectum and Anal Canal

SAQ Enterocutaneous fistula:management

1. Invertogram (S-20) (Pg. 957)

2. Internal Haemorrhoids (Pg. 961) (S-20)
3. Fistula-ln-Ano***** - classification; etiology, treatment of Low Fistula-In-Ano (W-19)(W-16)(S-15)
(W-11)(W-10)(W-02) (Pg. 971)
4. Chronic [Fissure-In-Ano]*** (W-18)(W-15)(S-12)(S-09)(W-08) (Pg. 967)
5. Imperforate Anus** (S-18)(S-12)(W-07) (Pg.957?)
6. Goodsall's Rule* (S-17)(W-07) (Pg. 973) c/f and
7. Haemorrhoids*** (Third Degree)- treatment* * (S-16)(S-13) (S-06)(W-05) (Pg. 963)
8. Anorectal Malformation - classification (S-15) (Pg. 957) (ARM)
9. Ischiorectal Abscess (W-14) (Pg. 970)
10. Sentinel Tag (W-13) (Pg. 969)
11. Perianal Abscess (W-12) (Pg. 970)
12. Rectum - surgical anatomy (S-12) (Pg. 942)
13. Anal Canal* - surgical anatonmy* (S-10)(S-05) (Pg. 943)
14. Pilonidal Sinus* - etiology, c/f, management (S-07)(W-03) (Pg. 958)
15. Carcinoma Rectum - treatment (S-03)
16. Malena - causes (W-02) (Pg. 980)

LAQ Carcinoma anal canal: c/f and management

1. Ca Rectum *** (Upper %) - C/F***, management***; pathology*; staging (W-19)(S-17)(W-12)(S-09)
(Pg. 946)
- -
2. 50year old male altered bowel habits since 2 months, faecal occult blood test positive
investigations, management (S-18) (Pg. 980)
3. Bleeding Per Rectum*** causes*** (part) (S-17) (W-16)(S-12)(S-09) (Pg. 980)
4. Rectum - surgical anatomy,managnRectal
Stage Carcinoma 15 cm from Anal Verge - investigations,
treatment (W-15) (Pg. 942, 947)
Urology
Kidney
SAQ

1. Congenital PUJ Obstruction** - management (W-19)(S-17)(W-02)

2. Dietl's Crisis (S-19) (Pg. 1001)
3. PUJ (Pelviureteric Junction) Obstruction* - management* (S-19)(W-09) (Pg. 1010)
Intravenous Pyelography*/Urography**** - indications, contraindications, method (W-18)(S-14)
(S-11)(W-08)(W-07)(S-07)(W-03) (Pg. 986)
5. Polycystic Kidney (W-17) (Pg. 994)
z6. Haematuria** - causes(W-16)(W-12)(\W-04) (Pg. 993)
7. Anuria (S-14)
8. Ureteric Injuries (W-13)
9. Staghorn Calculi* (S-13) (W-06) (Pg. 1011)
10. Wilm's Tumor* (S-13)(S-09) (Pg. 1012)
11. Horseshoe Kidney* (W-12)(S-07) (Pg.993)
12. Ureteric Stones - treatment options (S-12) (Pg. 1009)
13. Renal Calculi - etiology, types*; complications of untreated stone in Right PUJ (WN-10)(S-06) (Pg. 1005)
14. Hydronephrosis**** unilateral causes**; define; causes, investigations; unilateral ureteric causes
(S-10)(W-09)(S-08)(S-04)(W-03) (Pg. 1000)
15. Congenital Anomalies of Kidney (S-08)
16. Renal Carbuncle (W-07) (Pg. 1004)
17. Extracorporeal Shock Wave Lithotripsy (ESWL) (W-06) (Pg. 1007)
18. Perinephric Abscess (W-05) (Pg. 1005)
19. Kidney Tumors - classification (W-03) (Pg. 1012)

LAQ

1. Renal Cell Carcinoma ****** in a 70 y/o Diabetic Male Patient - etiopathology**,C/F*****,

management****, etiopathogenesis; spread; etiology, pathology**, investigations* (W-19)(W-18)
(W-16)(S-12)(S-10)(S-06)(S-05) (Pg. 1013)
2. Tuberculosis Kidney* - c/f", investigations, management*; etiopathogenesis (S-19)(S-04) (Pg. 998)
-
3. Painless [Haematuria]*** causes*** (part) (W-17)(S-14)(W-08)(S-06)
Hydronephrosis*** define**, causes** of U/L HN; types, c/f, investigations; Lower Ureteric Stone -
-
4.
management; Hydronephrosis due to Obstructing Ureteric Calculous - management; PUJ Obstruction -
management;Unilateral Hydronephrosis due to PUJObstruction - pathophysiology, c/f, management
(W-15)(S-15) (W-07)(VW-05) (Pg. 1000)
5. What is Grawitz Tumor (part) (S-10)
6. Wilm's Tumor - c/t, investigations, management (W-08)
7. Renal Calculi - c/f, management (W-04) (Pg. 1005)
Urinary Bladder
SAQ

1. Vesicoureteric Reflux (S-20) (Pg. 1028)

2. Ectopic Vesicae (W-09) (Pg. 1019)
3. Bladder Stone (W-05) (Pg. 1019) (vesical calculus)
4. Urinary Diversion - operations (W-03) (Pg. 1030)

LAQ

1. Carcinoma of Urinary Bladder***** - c/f****, management*****; etiopathogenesis****;

investigations;staging (W-17)(W-14)(S-14)(W-10)(S-07)(W-03) (Pg. 1023)
2. Traumatic Rupture of Urinary Bladder -c/f, investigations, management (S-11) (Pg. 1026)

Prostate
SAQ

1. Prostate Specific Antigen** (PSA)(W-17)(W-12)(W-06) (Pg. 1032)

2. Benign Prostatic Hyperplasia* - medical management; surgeries (S-15)(W-04) (Pg. 1033)
3. Prostatectomy (0pen & Endoscopic) - complications and management (W-09)

LAQ

Benign Prostatic Hyperplasia*** - c/f***, management***; investigations; etiopath ogenesis, recent

advances in treatment (S-16)(S-13)(W-11)(W-02) (Pg. 1033)

Urethra
SAQ

1. Urethral Stricture**-management*; causes (S-16)(S-08)(W-04) (Pg. 1043)

2. Superficial Extravasation of Urine (W-13) (Pg. 1046)
3. Acute* [Retention of Urine]* - causes** (S-12) (S-09) (S-07) (Pg. 1047)
4. Rupture of Bulbar Urethra (W-05) (Pg. 1041)
5. Hypospadias - surgical management*; classification according to position of meatus (S-04)(W-03) (Pg.
1044)

LAQ

-
1. Retention of Urine* define,difference from Anuria, causes, management of 60 y/o (W-06) (Pg. 1047)
2. Acute Retention of Urine - three common causes (part) (W-02)
Penis
SAQ

W1. Ca
Peni***- Precancerous Conditions*;etiology (W-19)(S-17)(S-10)(W-04) (Pg. 1051)
2. Phimosis* (W-15)(W-12) (Pg. 1048)
3. Paraphimosis* (S-13)(W-07) (Pg. 1049)
-
4. Circumcision*** indications, complications (S-09)(W-08)(W-05)(W-02) (Pg. 1049)

LAQ

1. Ca Penis** -c/f*, investigations, surgical management**; etiology, pathology*, spread*, staging

(S-19)(W-09) (S-03) (Pg. 1051) Premalignant conditions

Scrotum
SAQ

1. Congenital Hydrocele** (W-18)(W-15)(S-07) (Pg. 1058)

2. Fournier's Gangrene** (W-12)(S-10)(S-04) (Pg. 1056)
-
3. Varicocele** c/f,treatment (S-11) (W-06)(S-05) (Pg. 1063)
Scrotum enumerate layers; Uncomplicated U/L Hydrocele - surgeries (S-06)
-
4.
-
5. Primary & Secondary Hydrocele differences (W-03)

LAQ

1. Scrotal Swelling- D/D; Vaginal Hydrocele - etiology, c/t, management (S-09) (Pg. 1057)

Testis
SAQ Seminoma testis

1. Torsion Testis******** (W-17) (\W-14) (\W-13)(W-12)(S-12)(W-10)(W-07)(S-07)(W-05) (Pg. 1068)

2. Undescended Testis* - management*; investigations (S-16)(W-02) (Pg. 1067)
3. Testicular Tumors** - classification*; modes of spread (W-15)(S-07)(W-06) (Pg. 1070)
-
4. Undescended Testis and Ectopic Testis differences (S-10)

LAQ

Testicular Tumors**- classify**; c/f, management; Left Testicular [Seminoma]* - c/t, investigations,
management* (S-18)(S-17)(W-13) (Pg. 1070)
2. 25 y/o boy - hard left testicular mass and abdominal lump - D/D, management (W-12)
3. Undescended Testis - etiology, c/f, management (S-08)
Wounds and Wound Healing
SAQ

1. Keloid and Hypertrophic Scar - differences (S-03) (Pg. 14)

Swelling
SAQ Sebaceous cyst
1. Epidermal Cyst (S-18) (Pg. 77)

Electrolyte and Nutrition

SAQ Bariatric surgery

1. Enteral Feeding (W-11) (Pg. 96)

Burns
SAQ

1. Neck Burns Contracture - management (S-19) (Pg. 129)

2. Deep Burns - surgical management (S-06) (Pg. 126)

Hand and Foot

SAQ

1. Ingrowing Toe Nail (S-20) (Pg. 159)

2. Acute Suppurative Tenosynovitis (S-05) (Pg. 153)

Skin Tumors
SAQ

1. Rodent Ulcer (S-13) (Pg. 284)

Reconstruction
SAQ

1. Skin Grafting*** -
indications, types (W-19)(S-17)(W-16)(S-08) (Pg. 316)
2. Myocutaneous Flaps (W-18) (Pg. 320)
-
3. Flaps* types*; indications (S-15)(W-02) (Pg. 319)
4. Split Thickness/Thiersch's Skin Graft (S-14)(W-08) (Pg.316)
5. Partial & Full Thickness Skin Grafts - differences (S-04)

Faciomaxillary Diseases
SAQ

1. Dentigerous Cyst*** (W-19)(W-18)(S-17)(W-10) (Pg. 352)

2. Adamantinoma* (W-16)(W-03) (Pg. 351)
3. Cleft Lip*** (S-16)(S-15)(W-10)(W-07) (Pg. 338)
4. Epulis****** (S-15)(S-14)(W-13)(W-11)(S-11)(S-08)(W-05) (Pg. 350)
5. Dental Cyst (W-14) (Pg. 352)
6. Cleft Palate* (S-11)(W-07) (Pg. 338)
7. Pericoronitis - c/f, treatment (S-05)
8. Dental& Dentigerous Cyst - difference (W-03)

Oral Cavity
SAQ

1. Plunging [Ranula]* (S-18)(W-16) (Pg. 356)

Neck
SAQ

1. Cervical Rib* (S-13) (S-04) (Pg. 416)

Thyroid
SAQ
Thyroid surgical anatomy&
1. Thyroglossal Cyst (S-20) (Pg. 447)
Primanagement
2. Hyperthyroidism (S-18) (Pg. 460)
Breast
SAQ Ca breast management: recent advances

1. Phyllodes Tumor of Breast (S-18) (Pg. 512)

2. Mammography (S-13) (Pg. 507)
3. Breast Reconstruction (W-11) (Pg. 552)

Neurosurgery
SAQ

1. Meningomyelocele (S-08) (Pg. 1092)

Thorax
SAQ

-
1. Tension Pneumothorax****** c/f, management*; define (W-19)(S-19)(S-17)(S-14)(S-09)(W-06)(S-05)
(Pg. 1101)
2. Intercostal Drain - indications, complications (W-18) (Pg. 1105)
3. Empyema Thoracis** - define, causes, treatment modalities (W-14)(W-07)(S-06) (Pg. 1103)
4. Flail Chest*** define, management (S-12)(S-11)(W-08)(W-02) (Pg. 1100)
5. Pneumothorax (W-09) (Pg. 1101)
6. Open Pneumothorax (W-04)

LAQ

1. Hydatid Cyst - etiopathogenesis, sites; Hydatid Cyst of Lung - management (W-03) (Pg. 1109)

Cardiac Surgery
SAQ

1. Patent Ductus Arteriosus (S-18) (Pg. 1120)

2. Atrial Septal Defect (W-16) (Pg. 1121)
Adjuvant Therapy
SAQ

-
1. Interventional Radiology*; Radiotherapy* complications; methods of administration,adverse effects
(W-17)(S-16)(W-10)(S-05) (Pg. 1126)

Anaesthesia
SAQ

1. Spinal Anaesthesia********* -complications*(W-19)(w-17)(S-17)(w-15)(S-13)(5-12)(W-10)(5-09)(W

08)(S-06) (Pg. 1136)
2. Regional***/Local** Anaesthesia (S-19)(W-18)(S-17)(W-16)(S-15) (S-11)(W-09) (Pg. 1136)
3. General Anaesthesia (S-16) (Pg. 1133)
4. Epidural Anaesthesia*** (W-14)(W-11)(S-10) (S-04) (Pg. 1137)
5. Laryngeal Mask Airway (S-14) (Pg. 1134)
6. Xylocaine (W-13) (Pg. 1136)
7. Spinal & Epidural Anesthesia - differences, advantages, disadvantages (S-08)

Advanced Imaging Methods

SAQ Focussed assessment with sonography in trauma (FAST)
1. Surgery - indications (S-19) (Pg. 1143)
PET Scan in
2. Magnetic Resonance Imaging - principles (W-16) (Pg. 1142)
3. Endoscopic Ultrasonography** (W-15)(W-11)(W-04)
4. Doppler Examination Study (W-11) (Pg. 1140)

Operative Surgery
SAQ

1. ldeal Suture Material (S-20) (Pg. 1153)

2. Tracheostomy (S-20) (Pg. 1157)
3. Day Care Surgery (S-18) (Pg. 1165)
4. Vasectomy* (W-08)(W-04) (Pg. 1157)
Untitled
SAQ

1. Minimal Access Surgery - limitations (W-15)

2. X-Ray Examination - hazards of ionizing radiation (S-15)
3. Male Infertility (W-14)
4. Cardiopulmonary Resuscitation (CPR) (W-11)
5. TUR (W-03) (Pg. 1034?)

LAQ

1. Young female -h/o prolonged fasting over days -c/o abdominal pain, vomiting, distension, cherry red
-
stools management (S-20)
2. 50 y/o male - c/o lump in paraumbilical region, painless enlargement of left testis - investigation,
management (S-20)
 MPMSU Paper I - Obstetrics including social obstetrics and newborn care
Syllabus: -
Paper II Gynaecology, Family Welfare and Demography

OBGY-I: Obstetrics

Chapter 3: Placenta and Fetal Membranes

SAQ

1. Amniotic Fluid - functions (S-19) (Pg. 34)

2. Placenta* - functions* (S-14)(S-10) (Pg. 31)
3. Amniotic Fluid Index (W-13) (Pg. 35)

LAQ

1. Placenta - gross structure, functions (W-03) (Pg. 31)

Chapter 5: Physiological Changes during Pregnancy

SAQ

1. Haemodynamic Changes in Normal Pregnancy; Heart Disease in Pregnancy - criteria for diagnosis (S-04)
(Pg. 48)

LAQ

1. Physiological Changes in Cardiovascular System in Pregnancy* (part) (W-10)(W-09) (Pg. 48)

Chapter 7: Diagnosis of Pregnancy

SAQ Diagnosis of early pregnancy

1. Positive or Absolute Signs of Pregnancy (S-06) (Pg. 60)

Chapter 9: Fetal Skull and Maternal Pelvis

SAQ

1. Caput Succedaneum (S-06) (Pg. 78)

Chapter 10: AntenatalCare, Preconceptional Counseling and Care
SAQ

Oedema in Pregnancy (S-18) (Pg. 88)

1.
2. Routine Antenatal Care (W-15)

LAQ

1. 20 y/o primigravida - missed her period - comes to you for check-up for the first time - how will you
proceed (S-15)
2. Antenatal Care* - important components; define, components at first visit, time schedule for
subsequent visits in uncomplicated pregnancy (S-05) (S-03)

Chapter 11: Antenatal Assessment of FetalWell-Being

SAQ

-
1. Antenatal Assessment of Fetal Well-Being tests (S-19) (Pg. 96)
2. Non-Stress Test*** (W-16) (S-15) (W-11)(S-07) (Pg. 98)
3. [Biophysical Profile] ** Score (S-11)(W-09)(S-08)(S-06) (Pg.98)
-
4. Antepartum FetalSurveillance methods (W-02) (Pg. 97)

LAQ

-
1. Assessment of Fetal Well-Being at 34 weeks of gestation tests (W-14)

Chapter 12: Prenatal Genetic Counseling, Screening and Diagnosis

SAQ

1. Triple Markers in Pregnancy; Triple Marker Test (S-13) (W-12) (Pg. 103)

Chapter 13: Normal Labour

SAQ

1. Third Stage of Labour*** - active management*; physiology*, management (S-20)(W-16)(S-11)(W-05)

(Pg. 133)
2. Latent Phase of Labour (W-08) (Pg. 123)
3. Separation of Placenta - signs; Brandt-Andrew's Method - describe (S-03) (Pg. 133)
LAQ

i. Normal Delivery/ Labour - define" (S-18)(S-04) & 2nd stage management

2. Third Stage of Labour* - active [management]* (part) (S-18)(W-10) (Pg. 132, 134)
3. First Stage of Labour - physiology, clinical course (S-04) (Pg. 113, 121)

Chapter 14: Normal Puerperium

SAQ

1. Lochia* (S-17)(S-15) (Pg. 138)

2. Suppression of Lactation (W-14) (Pg. 142)
3. Postnatal Care (W-08) (Pg. 145)

Chapter 15:Vomiting in Pregnancy

SAQ

1. Hyperemesis Gravidarum*** (W-18)(W-16)(W-15) (S-12) (Pg. 146)

Chapter 16: Haemorrhage in Early Pregnancy

SAQ

1. Cervical Incompetence* - diagnosis, management (S-20)(W-16) (Pg. 161)

2. Ectopic Pregnancy - diagnosis (W-19) (Pg. 172)
3. MTP - complications (S-16) (Pg. 167)
4. MTP Act (W-14) (Pg. 164)
5. Threatened Abortion* - diagnosis, management (W-13)(S-05) (Pg. 153)
6. Missed Abortion** (S-11)(S-08)(W-04) (Pg. 155)
-
7. Ruptured Tubal Ectopic Pregnancy* management; diagnosis (S-10)(W-08)
8. Os-Tightening (Cervical Encirclage) (W-09) (Pg. 163)
9. Inevitable Abortion (W-06) (Pg. 154)
10. Hydatidiform Mole diagnosis, management (W-02) (Pg. 180)
Risk factors
LAQ
Types, measures to prevent unsafe abortions
Abortion define; First Trimester Abortion - etiology; Incomplete Abortion management (S-14)
- -
1.
2. Recurrent 2nd Trimester Abortions - causes; Cervical Incompetence in Pregnancy - management (W
12) (Pg. 161) Fate
3. TubalEctopic Pregnancy - etiology, c/f, diagnosis, conservative management (W-11) (Pg. 168)
4. Habitual Abortion - define; Incompetent Os - diagnosis, management (S-04) (Pg. 159)
Chapter 17: Multiple Pregnancy, Amniotic Fluid Disorders,
Abnormalities of Placenta and Cord
SAQ Different colour amniotic fluid: causes
G1PO32yr old with 30wk
1. Oligohydramnios* - etiology, complications (W-17)(S-16) (Pg. 203)
2. Acute Polyhydramnios (S-17) (Pg. 200) gestation, fundal height 36wk.
D/D and complications of twin
pregnancy
LAC Monochorionic twin pregnancy: complications

Pregnancy* - etiology*, diagnosis,management (W-13)(S-10) (Pg. 189)

1. Twin
2. Primigravida with Twin Gestation at 38 weeks of pregnancy - management (part) (S-10)
3. Multiple Pregnancy - diagnosis in detail; Labour in a Primigravida with Twin Pregnancy - management
(W-05)

Chapter 18: Hypertensive Disorders in Pregnancy

SAQ Pritchard regime
-
1. Pre-Eclampsia serious complications (W-19) (Pg. 213)
2. Impending Eclampsia (S-18)
3. Prevention of Pre-Eclampsia - prophylactic measures (W-17) (Pg. 214)
4. HELLP Syndrome (W-16) (Pg. 209)
5. Magnesium Sulfate* (S-15)(W-09) (Pg. 221)
6. Eclampsia* - management* (W-12)(S-12) (Pg. 217)

LAQ

1. Convulsions in Pregnancy - D/D; Eclampsia in labour - management (S-20) (Pg. 217)

2. Pre-EclampsiaBtiopathogenesis, c/F*, management; define; maternal & fetal risks;
Imminent/Impending Eclampsia - symptoms (S-16)(VW-15)(S-03) (Pg. 207)
3. Severe Pre-Eclampsia in 34 weeks pregnancy :management (W-15) (Pg. 214)
lassifv.
4. Hypertensive Disorders of Pregnancy - enumeråte; Eclampsia at 36 weeks of gestation - management;
-
Antepartum Eclampsia c/f, management (W-14)(S-08) (Pg. 217) 28 weeks 34 weeks Complications
-
5. Hypertension in Pregnancy define, classify; 32 weeks pregnancy with Mild Pre-Eclamptic Toxaemia
investigation, management (S-14)
6. Eclampsia** at fullterm - c/f, management**, complications**; define* (S-09)(\W-04)(W-03) (Pg. 217)
Pregnancy Induced Hypertension (PIH) - define, complications; Severe PIH at 32 weeks gestation
-
7.
management (W-07)
Primigravida 30 weeks gestation - BP= 150/100 mm Hg management (S-07)
- -
8.

weeks with convulsions, BP

G1 32 20yr old, 36wks gest,
G1

160/110. Provisional diagnosis With GHT & generalized tonic

and management clonic seizures.
Chapter 19: Antepartum Haemorrhage
SAQ

1. Placenta Previa - management (W-19) (Pg. 233)

2. Central Placenta Previa in Labour - management (S-14) (Pg. 228)
-
3. Abruptio Placentae* complications; management (S-04)(S-03) (Pg. 241)
Diagnosis
LAO & Placenta previa v/s Abruptio placentae distinguishing features

1. Bleeding per vaginum at 34 weeks D/D;Concealed [Abruptio Placentae]** at 34 weeks* of Gestation -

management**; diagnosis (W-18)(W-17)(W-09) (Pg. 237)
Antepartum Haemorrhage* - define*, causes (part) (W-17)(W-09) (Pg. 228) C/f
G2 with 36 weeks pregnancy presents with Bleeding Per Vaginum - D/D, investigations, management
(S-12) (previous c section)
4. Placenta Previa - c/f, diagnosis, treatment (S-09) (Pg. 228)
5. Accidental Haemorrhage - define;Concealed Accidental Haemorrhage - c/f, management (S-06) (Pg.
237)

Chapter 20: Medical and Surgical llnesses Complicating Pregnancy

SAQ

1. Perinatal Transmission of HIV Infection* -prevention*; Vertical Transmission of HIV Infection from
-
Mother to Child* measures to decrease; prevention (W-18)(S-07)(W-05)(S-05) (Pg. 283)
2. HIV Testing in Pregnancy (S-18) (Pg. 283)
3. Severe Iron Deficiency Anemia - treatment (S-17) (Pg. 247)
4. PPTCT Programme (S-17) (causes)
5. Parental Iron Therapy** (W-15)(W-11)(S-10) (Pg. 249)
6. Sickle CellCrisis in Pregnancy (W-13) (Pg. 255)
7. Social Factors for High Incidence of Anemia during Pregnancy (W-03)
(& physiological anemia) & G2P1 at 32wks with Hb 8gm% intolerant to
LAQ
oral iron therapy: management

1. Anemia in Pregnancy - definition, etiology, grades of severity, evaluation, management (W-19) (Pg.
245) Classify (maternal and fetal complications)
2. Iron Requirement Pregnancy; 20 week Pregnant Woman with Haemoglobin of & g/dl - management
in
(S-18) (Pg. 245)
3. Hepatic Disorders in Pregnancy - describe, management (S-16) (Pg. 270)
4. Heart Disease with Pregnancy - discuss antenatal care & labour (W-13)(Pg. 257)
5. Severe Anemia* in Pregnancy of 32 weeks - investigations*,management*, complications in pregnancy
and puerperium; effects on mother & baby (W-10)(W-02) (Pg. 245)
6. Mitral Stenosis in Pregnancy & Labour - management (W-09) (Pg. 260)

Diabetes in pregnancy: management

(screening)
Chapter 22: Preterm Labour and Birth, PROM, Postmaturity,
Intrauterine Fetal Death
SAQ Define PROM and write it's causes

1. Preterm Labour*** - define; etiology; treatment; diagnosis, D/D (W-10) (S-10)(S-07)(S-03) (Pg. 295)
2.. Intrauterine Death of Fetus (W-07) (Pg. 302)

LAQ
diagnosis Etiology, c/f
1. Preterm Labour***- commoncauses; define*; management;complications in a Preterm Baby (S
19)(S-11)(W-08)(S-05) (Pg. 294) Of primigravida 30wks with L.A pain
2. 34 y/o primigravida -32 weeks/30 weeks* of gestation with Preterm Labour** - management** (S
19)(S-11)(S-05) (Pg. 294)
3. Problems/Complications associated with Prematurity* (part) (S-11)(W-08)
4. Post-Term Pregnancy - define, diagnosis, management (W-06) (Pg. 299)

Chapter 23:Complicated Pregnancy

SAQ Trial of labor after c-section
1. Rh (Anti-D) Immunoprophylaxis*; Inj. Anti-D; Anti-D Immunoglobulin* (S-20)(W-18)(S-18)(W-07)(S-05)
(Pg. 314, 315)
2. Antiphospholipid Syndrome (S-14) (Pg. 321)
3. Coomb's Test (S-13) (Pg. 315)
4. Selection of a case of Previous Caesarian Section for Vaginal Delivery with monitoring this patient in
labour (W-10) (Pg. 309)

LAQ

-
1. Previous Caesarian Section history taking, clinical evaluation, management (W-08) (Pg. 307)
2. G2P1AOL1 with 37 weeks gestation - one Previous Caesarian Section - comes in labour - management
(S-07) (Pg. 309)

Chapter 24: Contracted Pelvis

SAQ

1. Types of Pelvis (S-16) (Pg. 325)

2. ClinicalPelvimetry* (W-08)(W-07) (Pg. 328)
Chapter 25: Abnormal Uterine Action
SAQ

1. Precipitate Labour (W-17) (Pg. 339)

LAQ

1. Bandl's Ring - write a note (part) (W-02) (Pg. 339)

Chapter 26: Complicated Labour: Malposition, Malpresentatiom and

Cord Prolapse
SAQ

1. Birth Injuries in Newborn in Breech Delivery* (S-20)(W-18) (Pg. 355)

2. Cord Prolapse in Labour - management (S-19) (Pg. 373)
-
3. Deep Transverse Arrest define,causes, diagnosis, management (W-04) (Pg. 349)
4. Assisted Breech Delivery (S-04) (Pg. 357)
5. Neglected Shoulder Presentation (S-03) (Pg. 370)

LAQ

-
1. Multigravida with Breech Presentation in Labour management (S-17) (Pg. 353)
2. G2P1 with 38 weeks of pregnancy admitted with labour pains - first delivery was by LSCS for Breech -
-

management (S-15)
3. Deep Transverse Arrest - causes, management (S-13) (Pg. 349)
Breech Presentation etiology, RF; Vaginal Breech Delivery criteria; Assisted Breech Delivery - discuss
- -
4.
(S-12) (Pg. 357) Types, c/f,diagnosis. management in primigravida
5. Occipito-Posterior position in Labour - diagnosis, management (S-11)(Pg. 343)
-
6. Malpresentations & Malpositions enumerate causes; Uncomplicated Breech Presentation during
Pregnancy & Labour - management (W-07)

Chapter 27: Prolonged Labour, Obstructed Labour, Dystocia caused by

Fetal Anomalies
SAQ Shoulder dystocia

Anencephaly (S-14) (Pg. 383)

1.
2. Hydrocephalus* (W-13)(W-04) (Pg. 381)

LAQ
Define labour, stages &:
-
1. Obstructed Labour* define, causes*, diagnosis, management (S-06) (W-02) (Pg. 379)
Complications
Chapter 28: Complications of the Third Stage of Labour
SAQ

1. PPH*** - etiology; prevention; high risk factors; treatment (W-19)(W-08)(W-03)(W-02) (Pg. 385, 387)
2. Atonic PPH - management (W-07) (Pg. 389)
3. Acute Inversion of Uterus (W-04) (Pg. 395)

LAQ
AMTSLEtiology & management of 1° PPH
PPH**** define****; management of various types; causes*; Atonic PPH**** - stepwise
.-
1.
management**** causes (S-17) (W-15)(W-10)(S-10)(S-08)(W-04) (Pg. 385) Diagnosis
Management during c-section

Chapter 29: Injuries to the Birth Canal

SAQ

1. Impending Rupture of Uterus during Labour in a Previous LSCS case - diagnosis (S-19) (Pg. 401)

LAQ

-
1. Ruptured Uterus causes, management (W-06) (Pg. 400)

Chapter 30: Abnormalities of the Puerperium

SAQ

1. Fever in Puerperium* - causes*; Puerperial Sepsis - management (W-18)(S-05) (Pg. 406)

2. Complications of Puerperium (S-16)

LAQ

1. 27 y/o primigravida - delivered normally 7 days back - came back with fever, pain in abdomen - cause,
management (W-17) (Pg. 406)
2. Puerperal Pyrexia - define, etiology; Puerperal Sepsis* - management* (W-12)(W-05) (Pg. 406)
3. Fever in Puerperium - causes (part) (W-05) RE, causative organisms

Chapter 31: The Term Newborn Infant

SAQ

1. Breast Feeding - merits (S-09) (Pg. 421)

 2. Baby Friendly Hospital Initiative* - eight steps laid down by UNICEF (S-08)(S-06) (Pg. 421)
3. Exclusive Breast Feeding (W-06) (Pg. 421)

Chapter 32: Low Birth Weight Baby

LAQ Diff between symmetrical and asymmetrical IUGR

1. Intrauterine Growth Restriction* - define, classification, etiology*; diagnosis, management;

Asymmetrical IUGR - management (W-16)(W-11) (Pg. 431)

Chapter 33: Diseases of Fetus and Newborn

SAQ

1. Cephalohematoma** (W-17)(S-08)(W-04) (Pg. 452)

2. Neonatal Resuscitation*** (W-15)(S-13)(W-11)(W-10) (Pg. 442)
3. APGAR Score***** (S-15)(S-14)(W-13)(S-11)(S-10) (W-03) (Pg.440)
4. Neonatal Jaundice**** (W-14)(S-13)(W-12)(S-09) (S-07) (Pg. 446)
5. Birth Asphyxia; Asphyxia Neonatorum (W-12)(W-10) (Pg. 438)
6. Down's Syndrome (W-06) (Pg. 460)
7. Birth Injuries in Newborn (W-05) (Pg. 451)

Chapter 34: Pharmacotherapeutics in Obstetrics

SAQ Misoprostol: various uses in obstetrics

Uterine Relaxants; Tocolytics - enumerate, mechanism of action, toxicity (S-16)(W-10) (Pg. 471)
1.
2. Oxytocin (W-15) (Pg. 464)
3. Magnesium Sulfate* (S-15)(W-09)(Pg. 472, 473)

Non contraceptive benefits of OCPs

Chapter 35: Induction of Labour

SAQ

1. Partogram**/Partograph***** -draw, label (W-19)(W-14)(S-13)(S-12)(S-09)(S-07)(W-06) (Pg. 491)

K2. Bishop's Score (S-19) (Pg. 486)
3. Medical Induction of Labour (S-04) (Pg. 485)
4. Induction of Labour - indications, methods (W-02)
LAQ

1. Induction of Labour* - define*, indications, methods* (S-19)(\W-16) (Pg. 485)

Chapter 37: Operative Obstetrics

SAQ

1. External Cephalic Version*** (S-20)(S-12)(W-09)(S-05) (Pg. 541, 356)

-
2. Outlet*/Low Forceps* prerequisites* for application (W-18)(W-09) (W-05) (Pg. 533)
3. Forceps Delivery* - prerequisites* (S-15) (W-14) (Pg. 533)
4. Manual Vacuum Aspiration (S-12) (Pg. 527)
5. Ventouse; Vacuum Extraction (W-11)(W-06) (Pg. 538)
6. Episiotomy*** (S-11)(S-08)(S-04)(S-03) (Pg. 528)
7. Forceps and Vacuum Application - advantages, disadvantages (W-10) (Pg. 533)
8. Lower Segment Caesarian Section - indications (S-09)(Pg. 546)

LAQ

1. LSCS - indications, intraoperative & postoperative complications (S-20) (Pg. 546, 552)

Chapter 38: Safe Motherhood, Epidemiology of Obstetrics

SAQ LAQSHYA programme

1. Maternal Mortality*** Rate - causes**, prevention in developing country; define (W-10) (S-06)(W
05)(W-03) (Pg. 558)
2. Safe Motherhood (S-09) (Pg. 557)
3. Perinatal Mortality (W-02) (Pg. 561)

LAQ

-
1. Maternal Mortality define, causes, preventable factors (S-13) (Pg. 558)

Chapter 40: Current Topics in Obstetrics

SAQ

1. PCPNDT Act* (S-18)(W-11) (Pg. 597)

Chapter 41: Imaging, Amniocentesis and Guides to Clinical Tests
SAQ

1. Role of USG in Third Trimester (S-17) (Pg. 605)

2. Glucose Challenge Test (W-12) (Pg. 611, 263)
3. Ultrasonography in First Trimester (W-07) (Pg. 601)
4. Ultrasonography in Obstetrics - uses (W-03) (Pg. 591)

LAQ

1. Amniocentesis - criteria, indications, procedure, complications (W-19) (Pg. 607)

Untitled
SAQ

1. EssentialObstetric Care (W-17)

 OBGY- Il: Gynaecology

Chapter 4: Congenital Malformation

SAQ Embryogenesis of female genital organs
1. Septate Uterus (S-16) (Pg. 35)
2. Imperforate Hymen (S-10) (Pg. 32)
3. Hematocolpos (S-05) (Pg. 31, 371)

Chapter 6: Menopause

SAQ

1. HRT* - benefits; indications, dosage, s/e (S-19)(W-18) (Pg. 50)

LAQ

1. Menopause - symptoms; Hormone Replacement Therapy - role in present day Gynaecology (W-04) (Pg.
48)

Chapter 8: Mestruation
SAQ

1. Graafian Follicle (W-18) (Pg. 68)

2. Menstrual Regulation** (S-11)(S-09)(W-04)
3. Secretory Phase (S-07) (Pg. 72)

LAQ

1. Physiology of Menstruation* (part) (W-19)(W-06) (Pg. 66)

2. Normal Menstrual Cycle - neuroendocrinology (S-17)

Chapter 9: Examination and Diagnostic Procedures

SAQ

1. Colposcopy*** (W-19)(W-16)(W-15)(S-10) (Pg. 93)

2. Pap Smear***; Evaluation of Abnormal Pap Smear (S-19)(W-14)(W-13)(S-04) (Pg. 89)
3. Genital Malignancy - screening (S-16) (Pg. 92)
 4. Cervical Malignancy - screening (S-13) (Pg. 92, 267)

Chapter 10: Imaging Techniques, Diagnostic Procedures, Laser

SAQ

1. Hysteroscopy** (W-13)(S-08)(W-07) (Pg. 102, 510)

Chapter 11: Pelvic Infection

SAQ

1. Acute PID* - management* (W-16)(W-09) (Pg. 106)

2. Genital Tuberculosis* - diagnosis, management (W-15)(S-08) (Pg. 113)
3. Tuberculous Salphingitis (S-14) (Pg. 114)
4. Acute Pelvic Infection - symptoms, signs (S-12) (Pg. 106)

LAQ

1. Acute PID*** -D/D, etiopathology, diagnosis*, management***, complications*; define*, predisposing

factors*", organisms*; c/f (S-20)(W-12)(W-10)(S-07)
2. Pathology of Fallopian Tubes in Genital Tuberculosis (part) (S-10) (Pg. 114)

Chapter 12: Sexually Transmitted Infections

SAQ Syndromic management of STIs, how is it more useful than lab
based management
1. BacterialVaginosis** (S-16)(S-15)(W-14) (Pg. 124)

LAQ

1. Gonorrhea in adult female - signs, symptoms, treatment (S-10) (Pg. 120)

Chapter 13: Infections of Individual Pelvic Organ

SAQ

-
1. Trichomonas Vaginalis ***** c/f, diagnosis, management (S-17)(S-13)(S-11)(W-10)(W-06)(W-05) (Pg.
133) Diagnosis, management, RF
2. Vaginal Candidiasis***/Monilial Vaginitis* (W-16)(W-11)(W-08)(S-08) (S-07)(S-04) (Pg. 135)
3. Leucorrhea due to Candida Albicans (S-06) (Pg. 135)
4. Atrophic Vaginitis (W-03) (Pg. 136)
Chapter 14: Dysmenorrhea and Other Menstrual Cycle Disorders
SAQ

1. Congestive Dysmenorrhea (W-14) (Pg. 148)

2. Spasmodic Dysmenorrhea* (S-14)(W-11) (Pg. 146)
3. Premenstrual Syndrome (S-12) (Pg. 149)
4. Dysmenorrhea (S-03) & it's types

LAQ

Dysmenorrhea* - define*; Primary Dysmenorrhea* treatment; causes, c/f, management (S-10)(W-08)

-
1.
2. Menstrual Disorders- enumerate (part) (W-06)

Chapter 15: Abnormal Uterine Bleeding

SAQ Iron sucrose use

*1.2. Puberty Menorhagia - management (S-20)

DUB- conservative management (W-17) (Pg. 157)
3. Metropathia Hemorrhagica (W-02) (Pg. 155)
LAQ

Diagnosis
AUB***- management*; define*; classification, causes; D/D; 40 y/o woman with AUB - evaluate (W
19](S-19)(W-18)(W-09) (Pg. 161, 157)
2. DUB**** - define*, classification; diagnosis & management** in a Perimenopausal Woman*; 15 y/o
girl with Puberty Menorrhagia with Anemia - management (W-16)(S-15)(S-11)(W-09)(W-05)
3. Abnormal Bleeding PV - causes (part) (S-15)
-
4. Menorrhagia*- define*, causes*, medical management; 16 y/o girl with Menorrhagia investigations,
management (W-13) (S-13) (Pg. 152) D/D
5. Metropathia Hemorrhagica - c/f, investigations, management (S-11) (Pg. 155)

Chapter 16: Displacement of Uterus

SAQ

1. Supports of Uterus*** (W-18)(S-15) (S-09)(W-03) (Pg. 165)

2. Decubitus Ulcer (W-11) (Pg. 170)
3. Cystocele (S-11) (Pg. 168, 171, 172, 175)
4. Vault Prolapse (W-05) (Pg. 180)
5. Genital Prolapse - Preoperative Management (w-04)
6. Manchester Operation (S-03) (Pg. 177)
LAQ
(& importance) Nulliparous Classification
Supports
1. Uterus****- describe****;
of UV
Prolapse****- define, etiology***; RE, c/f, complications,
treatmernt; 24 y/o woman with Second Degree Prolapse of Uterus management; [30 y/o woman with
Third Degree Cervical Descent - management]*; [29/50/45/25 y/o woman with Third Degree UV
Prolapse - management; diagnosis]***** (S-20)(W-19)(S-19)(S-18)(W-16)(W-14)(S-13)(S-12)(S-07)(S
04) (Pg. 165) & POP-Q classification
-
Genital Prolapse* classification; predisposing factors (part) (S-12)(S-07) (Pg. 169)
3. 26 y/o female - h/o one fullterm normal delivery - presents with Third Degree Genital Prolapse
-

management (S-06) Preventive measures

Chapter 17: Infertility

SAQ Hyperprolactinemia
-
1. Ovulation****** tests* for diagnosis**;induction** (S-20)(S-19)(S-15)(W-10)(S-10)(W-07)(W-02)
(Pg. 192, 198)
2. Male Infertility* - causes* (S-17)(W-04) (Pg. 187)
3. Tubal Patency Tests (S-14) (Pg. 194)
4. Semen Analysis*** (S-11)(S-08)(S-05)(W-03) (Pg. 190)
5. Intrauterine Insemination (W-04) (Pg. 203)
6. Female Infertility - causes (S-04) (Pg. 188)

LAQ & fallopian tube patency tests)

Primary
1. Female Infertility* - causes*, investigations, management (W-18)(W-11) (Pg. 186)
-
3. Ovulation**- how to detect; tests*; Anovulation*** in Infertile Woman management**; drugs;
Ovulatory Infertility - management (W-17)(S-16)(W-14)(W-11) (S-09) (Pg. 192, 198)
3. Infertile Couple* - investigations* (part) (S-16)(S-09)
4. Tubal lnfertility - causes, management (S-06)
5. Uterine & Tubal Factors of Infertility - enumerate,tests to evaluate (S-03)

Chapter 19: Benign Lesions on the Cervix

SAQ Lymphatic drainage of cervix

1. Cervical Erosion*** (S-17)(W-14)(W-11)(W-07)

Chapter 20: Benign Lesions of the Uterus

SAQ

Submucous Fibroid* of 4 cm in 32 y/o - management (W-17)(S-04) (Pg. 227)

1.
2. Myomectomy* - principles (W-15)(S-11)(S-06) (Pg. 229, 498)
 3. Red Degeneration of Fibroid (W-11) (Pg. 224)
4. Uterine Fibromyoma - complications (W-09) (Pg. 226)

LAQ Anatomical classification

Types;mngmt of large intramural fibroid at 45yr age
Uterine Fibroids**- etiology, diagnosis, management; symptoms*, signs; 30y/o patient with
-
symptomatic Fibroid management (S-17)(S-11)(W-04) (Pg. 221)
-
2. Myomectomy* selection criteria; principles, counselling (part) (W-04)(S-03) (Pg. 229)
3. Enlargement of Uterus - causes (part) (S-03) (Pg. 225)

Chapter 21: Benign Lesions of Ovary

SAQ

1. Ovarian Tumors - classify (W-19) (Pg. 237)

2. Dermoid Cyst******* of Ovary* (W-17)(S-16)(S-15)(S-13)(S-09)(W-08)(W-06)(S-06)(S-05) (Pg. 239)
3. Parovarian Cyst (W-16) (Pg. 246, 31)
4. Benign Ovarian Cyst* - c/f* (W-10)(S-07) (Pg. 235)
5. Twisted Ovarian Tumor - treatment (W-03) (Pg. 243)

LAQ

1. Ovarian Cyst - types of complications; Twisted Ovarian Cyst - management (W-09) (Pg. 243)
2. Benign Ovarian Tumors in 35 y/o - c/f, management (S-04)
Causes

Chapter 22: Endometriosis and Adenomyosis

SAQ

1. Adenomyosis (W-19) (Pg. 265)

2. Chocolate Cyst of Ovary (S-17) (Pg. 252)
3. Endometriosis* - medical* treatment/management (W-08)(W-06) (Pg. 253)

C/f and theories of pathogenesis

- -
1. Endometriosis define; Endometriosis in 28 y/o Infertile patient with Severe Dysmenorrhea medical &

surgical management (W-15)

Chapter 23: Premalignant Lesions

SAQ

1. HPV Vaccine* (S-19)(W-13) (Pg. 268, 272, 285)

2. Loop Electrosurgical Excision Procedure (LEEP) (S-18) (Pg. 269, 273)
 3. Paget's Disease (S-12) (Pg. 261)
4. Cervical Cancer Screening - methods (W-03) (Pg. 265, 90)

LAQ

1. Cervical Intraepithelial Neoplasia - diagnosis, management (S-15) (Pg. 265)

& RF

Chapter 24: Genital Malignancy

SAQ

1. Krukenberg Tumor (S-18) (Pg. 319, 546)

2. Vescicular Mole - follow up after evacuation (S-14) (Pg. 302)
Carcinoma Cervix*** - FIGO Staging**; predisposing factors (W-08)(S-07)(W-06) (S-03) (Pg. 282)
-50yo P7L7 menopausal lady with bleedingp.v. since 2 days: d/d &
LAQ

-
1. Malignant Ovarian Tumor ultrasonography features (S-20) (Pg.309)
2. Ca Endometrium**** - diagnosis, management**; etiology; FIGO staging; Stage IB Ca Endometrium -
management;Stage ICa Endometrium - c/f, investigations, management (W-17)(W-15)(W-10)(W
08)(S-08) (Pg. 292)
3. Corpus Cancer Syndrome - define (part) (W-17) (Pg. 292)
4. Carcinoma Body of Uterus - diagnosis, management (S-16) RF Screening guidelines
Carcinoma Cervix*** - etiology, c/f, management; clinical staging**; methods for early detection; Ca
Cervix Stage IB*; lIB evaluation, management**; c/f (S-14)(W-12) (S-09)(W-07) (Pg. 280) Prevention
6.
Hydatidiform Mole - define;Choriocarcinoma - signs, symptoms, management (S-12) (Pg. 298)
Ovarian Malignancy/Carcinoma - c/f*,management; Epithelial Ovarian Cancer diagnosis,
-
7.
management (W-11)(S-06) (Pg. 304)
8. Fractional Curettage - add a note (part) (W-03)
(molar pregnancy)
(follow up)
Chapter 25: Ürinary Problems in Gynecology
SAQ

1. Stress Urinary Incontinence - define, tests, management (W-18) (Pg. 328)

Chapter 26: Genitourinary Fistula

SAQ

1. Three Swab Test (W-12) (Pg. 345)

Chapter 28: Disorders of Sexual Development
SAQ

1. Turner's Syndrome** (W-15)(S-07)(W-02) (Pg. 363)

2. Testicular Feminization Syndrome (S-15) (Pg. 364)
3. Klinefelter's Syndrome (W-09) (Pg. 365)

Chapter 29: Amenorrhea

SAQ Primary amenorrhea & it's Etiology

1. Cryptomenorrhea** (S-18)(S-12)(W-05) (Pg. 371)

2. Asherman's Syndrome (S-03) (Pg. 378, 551)

LAQ

1. Polycystic Ovarian Syndrome - management (W-13) (Pg. 378)

Chapter 30: Contraception

SAQ Permanent contraception methods

1. Emergency Contraception****** (S-20)(S-19)(W-17)(W-14)(W-10)(S-10)(W-06) (Pg. 404)

2. Combined OC Pills* (W-19)(W-15) (Pg. 398)
3. Mirena*/Levonorgestrel-Intrauterine System (S-18) (S-14)(S-12) (Pg. 393)
4. Laparoscopic Tubal Sterilization*; Minilap Tubal Ligation (S-16)(S-13)(S-06) (Pg.410)
s.
IUCD*- contraindications; complications (W-13) (W-12) (Pg. 393)
6. Progesterone as contraceptive (S-13) (Pg. 403)
7. Female Condom (W-12) (Pg. 412)
8. Contraception for Breast Feeding Woman (W-12) (Pg. 403)
9. Injectable Contraceptives (S-08)
10. Copper-T(W-07): Indication& contraindications (Cu-T 375A)
11. Benefits of Oral Contraceptives (S-06) (Pg. 401)
12. Condom (W-05) (Pg. 412)
13. Missing Threads of IUCD (S-05) (Pg. 396)
14. Barrier Contraception (W-02) (Pg. 412)

LAQ Hormonal contraception: diff methods, benefits and hazards of each

1. Temporary Contraception - methods; IUCD - indications, contraindications (S-08)

2. Couple who have completed family size - list of sterilization methods; Explain the Consent to the
couple; No-Scalpel Vasectomy - write in brief (W-02) (Pg. 406)
Contraception options for a Post partum lady
Chapter 31: Radiotherapy, Chemotherapy, Immunotherapy and Gene
Therapy
SAQ

1. Tumor Markers* in Gynaecology (W-19)(S-09) (Pg. 431, 311)

2. Methotrexate (S-10) (Pg. 427)

Chapter 32: Hormones in Gynecological Practice

SAQ

1. Clomiphene Citrate (S-17) (Pg. 440, 199)

2. Danazol (S-09) (Pg. 438, 254)

Chapter 34: Special Topics

SAQ Natural defence mechanism of female genital tract.

Hirsutism* (W-18)(W-09) (Pg. 473)

1.
2. Post-Menopausal Bleeding** -evaluation; causes (S-18)(W-13) (S-05) (Pg. 462)
3. Leucorrhea (W-17) (Pg. 456)

LAQ Ovarian dysfunction: diagnosis and management

1. Lump in Lower Abdomen*; 18 weeks Lump in Abdomen arising from pelvis in 40 y/o woman - D/D**;
management (S-18)(W-07)(S-05) (Pg. 470)
2. Post-Menopausal Bleeding**i*** pV - causes***; investigations* (part) (S-16)(W-15)(W-10)(S-08)(W-03)
(Pg. 462) & management
woman - -
3. 38 y/o h/o Chronic Pelvic Pain evaluation, management (S-14) (Pg. 460)
4. Excessive Vaginal Discharge - clinical evaluation (W-02) (Pg. 456)

Chapter 35:Operative Gynecology

SAQ Endoscopic surgeries in gynecology: advantages and disadvantages

1. Hysterosalphingography (W-08) (Pg. 487, 194)

2. Laparoscopy in Gynaecology (W-05) (Pg. 506, 101)

LAQ

1. Laparoscopy in Gynaecology - indications (S-05) (Pg. 506, 102)

Untitled
SAQ

1. Forniceal Mass in young patient - D/D (W-04)

2. Carcinoma-In-Situ (W-02)

Obstetrics
1. Ectopic Pregnancy - medical management (S-20o)
2. Medical Abortion (W-16)
3. MTP Act**; First Trimester MTP - methods (W-12)(W-10)(W-07)(S-03)
4. Manual Vacuum Aspiration (W-09)
5. Ruptured Tubal Ectopic Pregnancy - diagnosis, management (S-04)

LAQ
What is Social obstetrics, how can you contribute as medical doctor
1. 1st Trimester MTP - enumerate methods, describe any one in detail (W-06)
2. Woman having 8 weeks Amenorrhea - Abdominal Pain with Vaginal Bleeding - causes;Ruptured
Ectopic Pregnancy - confirmation (W-03)
Paediatrics

2: Growth
SAQ Growth faltering
1. Microcephaly (S-20) (Pg. 36)

3: Development Milestones from birth to 1 year

SAQ Principles of development.
1. Normal Motor Development in First Year of life (W-08) (Pg. 40)

4: Developmental and Behavioural Disorders

SAQ
Attention deficit hyperactivity disorder:
clinical diagnosis & management.
1. Pica (W-11) (Pg. 57)
2. Thumb Sucking (S-05) (Pg. 57)

5: Adolescent Health & Development

SAQ

1. Physiology of Puberty (S-19) (Pg. 61)

2. Sexual Maturity Rating for Adolescents (W-16) (Pg. 60)
3. Psychological Problems during Adolescence (W-6) (Pg. 62)

LAQ

1. Stages of Adolescence; Health Problems of Adolescents (S-17) (Pg. 60)

6: Fluid & Electrolyte Disturbances

SAQ

1. Metabolic Acidosis* in children (S-18)(S-04) (Pg. 83)

 7: Nutrition
SAQ

1. Complementary Feeding* for an infant (S-20)(W-16) (Pg. 91)

2. Sever Acute Malnutrition** (SAM) - nutritional [management]*; complications (S-17) (W-15) (S-08) (Pg.
97)
3. PEM - classification (W-04) (Pg. 94)
4. Nutritional Rehabilitation Center (S-03) (Pg. 99)

LAQ
(10 steps) (nutritional mng. in 2yo child)
(child with persistent diarrhoea)
Severe Acute Malnutrition (SAM)- define; 18 m/o with SAM - c/f, investigations, management,
X1. potential complications (W-14) (Pg. 97) Indication of 'failure to respond'e
2. Kwashiorkor - etiopathogenesis, c/f, diagnosis, management (W-11) (Pg. 96)

8: Micronutrients in Health & Disease

SAQ

1. Vitamin B12 (S-19) (Pg. 119)

2. Vitamin D Deficiency (W-17) (Pg. 112)
3. Nutritional Rickets** - management (W-11)(S-06)(W-05) (Pg. 112)
4. Scurvy* (W-10)(W-03) (Pg. 121)
5. Xerophthalmia (W-09) (Pg. 110)
6. Vitamin A Deficiency (W-06) (Pg. 110)
7. Trace Elements (S-03) (Pg. 122)

LAQ

- VWHO
1. Vitamin A Deficiency classification, management in children (S-20) (Pg. 110)

9: Newborn Infants Essential newborn care.

SAQ

1. Unconjugated Hyperbilirubinemia in a Neonate (S-20) (Pg. 168)

2. New Ballard Score Maturational Assessment of Gestational Age (W-19)(Pg. 138)
3. Exclusive Breast Feeding; Breast Feeding - advantages (S-19)(S-12) (Pg. 145)
4. Neonatal Jaundice*; Neonatal PhysiologicalJaundice**- treatment* (W-18) (W-14)(W-09)(w-05)(S-03)
(Pg. 169; 168) Neo. Hyperbilirubinemia causes and
5. Warm Chain* (W-17) (S-07) (Pg. 143/145 - Ghai 8th Edition) diff b/w patho & physio ne0. Jaundice
6. Neonatal Reflexes (S-17) (Pg. 141)
-7. Hypothermia in Neonates/Neonatal Hypothermia (W-16)(S-15) (Pg. 143)
8. Neonatal Sepsis* - investigations, treatment (S-14)(S-09) (Pg. 160)

(Prevention at birth and transport)

(Management)
 Neonatal Resuscitation Protocol (S-13) (Pg. 128)
10. Low Birth Weight Baby - complications (S-13) (Pg. 150)
11. Newborn with APGAR SCore less than 3 - delivery room resuscitation (W-12) (Pg. 127)
12. Hypoglycemia (W-07) (Pg. 175)
13. Weaning (S-05)
14. Diaper Rash - define, presentation, treatment (W-04) (Pg. 136)
15. Micronutrient Supplementation of Breast Milk for LBW Babies (S-04)
16. Breast Milk - immunological factors (W-02) (Pg. 145)
(Banking)
LAQ

1. Low Birth Weight Baby - define, complications; Respiratory Distress Syndrome - management (S-18)
(Pg. 149,165)
2. Preterm Baby - complications; Preterm Baby with Hyaline Membrane Disease (Respiratory Distress
Syndrome*) - c/f*, diagnosis, treatment; management (S-16)(S-12) (Pg. 165, 150)
3. Respiratory Distress* in a Newborn* - causes; D/D, management; etiology, c/f(part) (S-12)(W-08)(W
04)
4. 28 hour old Newborn - delivered at home -presents with Severe Jaundice - c/f, D/D, management (S
10) (Pg. 168)
-
X5. Neonatal Resuscitation* equipment, steps* (W-07)(W-02) (Pg. 126)
6. Normal Newborn Baby - routine care (S-07) (Pg. 133)
7. Breast Feeding - techniques, advantages, contraindications,common problems (W-06) (Pg. 147)

10: Immunization & Immunodeficiency

SAQ

1. Injectable Polio Vaccine*; Inactivated Polio Vaccine (|PV) (W-15)(W-13)(W-09) (Pg. 188)
2. Child with Bite by Rabid Dog - management (W-14) (Pg. 198)
3. DPT Vaccine* - adverse effects (S-14)(S-13) (Pg. 189)
4. Pulse Polio Program (S-12) (Pg. 184)
5. Measles Vaccine (W-08) (Pg. 191)
6. Oral Polio Vaccine (S-08) (Pg. 186)
7. BCG Vaccine (S-06) (Pg. 185)
8. Hepatitis B Vaccine (W-05) (Pg. 192)
9. MMR Vaccine (S-05) (Pg. 192)
10. Typhoid Vaccine (W-04) (Pg. 195)
11. Immunization Schedule for Newborn Baby (S-04) (Pg. 186)
12. Universal Immunization Program (UIP) (W-03) (Pg. 187)

11: Infections and Infestations

SAQ

1. Dengue Shock Syndrome* - management (W-19)(W-15) (Pg. 222)

 -
2. Malaria* laboratory diagnosis; complications, treatment (S-16)(S-14) (Pg. 256)
3. Measles*** -complications*** (S-16) (W-14)(W-11)(5-07) (Pg. 211)
4. Fever* in a 3 y/o - classify as per IMNCI guidelines; management (W-15) (S-07) (Pg. 206, 782)
5. HIV in children - prevention (S-15) (Pg. 230)
6. Mantoux Test* (W-14)(S-10) (Pg. 246)
7. Parent to Child Transmission of HIV - prevention (W-08) (Pg. 230)
8. Directly Observed Short Term Chemotherapy Strategy (S-08) (Pg. 248)
9. Enterobius Vermicularis Infection (W-05) (Pg.265)
10. Oral Thrush (S-05) (Pg. 253)
11. Newer Antimalarials (S-03) (Pg. 258)
12. Artemisinin Derivatives (W-02) (Pg. 257)

LAQ

1. Fever with Rash* since 4 days in a 3 y/o child - causes*; Measles* - c/f*, complications*,prevention*
(S-18) (Pg. 208)
2. Primary Complex - define, natural course, investigation, management in a child (S-15) (Pg. 244)
3. Dengue Fever - etiopathogenesis, c/f, diagnosis, management (W-09) (Pg. 219)
4. Childhood Tuberculosis (S-04) (Pg. 243)
5. Enteric Fever- pathology,c/t, complications, management (S-03) (Pg. 238)

12: Disorders Gastrointestinal System & Liver

SAQ
Persistent diarrhoea: define& dietary management
1. [Assessment of a Sick Infant with Diarrhoea as per IMNCI Syndromic Approach]* (W-19)(S-13) (Pg. 288,
781)
2. Acute Liver Failure - management (W-18) (Pg. 312)
3. ViralHepatitis (W-17) (Pg.310)
4. Revised WHO [Oral Rehydration Solution]***** (W-11)(S-10)(S-09)(S-08)(W-06)(W-03) (Pg. 289)
5. Hirschsprung Disease (S-10) (Pg. 280)
6. Management of Diarrhoea - Plan C (W-07) (Pg. 290) Plan B
7. Lactose Intolerance (W-02) (Pg. 294)

LAQ
(c/f)
Dehydration - four signs; Hypovolumic Shock management; Oral Rehydration Therapy - advantages,
-
1.
limitations (S-06) (Pg. 287)
2. Acute Diarrhoea in children - causes*, management*;c/f, complications (W-05)(S-05) (Pg. 287)
13: Hematological Disorders
SAQ

1. Thalassemia** Major* - recent advances in management*; treatment; chelation therapy* (W-19)

(W-13)(W-12)(S-12)(W-08) (Pg. 340)
2. Sickle Cell Crisis (S-19) (Pg. 342)
-
3. Nutrional Anemias treatment (S-18) (Pg. 335) Causes, c/f, investigations
4. Hemophilia (S-17) (Pg. 351)
5. Iron Deficiency Anemia* - treatment,; management (S-16)(S-12) (Pg. 333)
6. Haemorrhagic Disease in Newborn* (W-13)(W-04) (Pg. 351, 117)
7. Megaloblastic Anemia of Infancy (W-07) (Pg. 334)

LAQ Child with recurrent bleedingepisodes: diagnostic approach

1. Idiopathic Thrombocytopenic Purpura - c/t, investigations, treatment (W-18) (Pg. 349)
2. Sickle Cell Disease* - enumerate all crises; c/f, management; Vaso-occlusive Crisis - management
(W-17) (W-06) (Pg. 342)
3. Anemia* - define, classify; causes in children (part) (W-15) (S-14) (Pg. 329)
Thalassemia Major***- investigations*, treatment; c/f**, management***; etiopathogenesis;
etiology, pathology; current concepts (W-15)(W-10)($-09)(S-08)(S-06) (Pg. 339)
-
S. Iron Deficiency Anemia management (S-4tB 995) Diag. approach to Microcytic
- causes,
6. Hemolytic Anemia laboratory diagnosis (part) (S-09) hypochr. anemia algorithm/chart
7. Enumerate four conditions that can present with Anemia and Hepatosplenomegaly in 8 m/o infant
(S-06)
- -
8. 6 y/o boy requires frequent Blood Transfusion has Hepatosplenomegaly etiology, diagnosis,
treatment (W-05)

15: Disorders of Respiratory System

Pertusis: Etiology & pathogenesis
SAQ
(Status Asthamaticus)
Acute Severe Asthma in children - management (S-20) (Pg. 389)
1.
2. Bronchial Asthma* - preventive therapy; inhalational therapy (S-18)(W-02) (Pg. 383; 385)
3. Bronchiolitis (W-16) (Pg. 380)
4. Acute Respiratory Tract Infection (ARTI) Programme (S-07) (Pg. 380)

LAQ

Symptoms
1. Bronchial Asthma** in children - c/f", investigations, stepwise management*; classification,
pharmacological management; prevention (W-18)(S-15)(W-09) (Pg. 382)
2. Pneumonia* in 2 y/o - etiology, c/f, management* (S-13)(W-04) (Pg. 377)
 Nadas criteria for
16: Diorders of Cardiovascular System congenital heart disease
SAQ

1. Patent Ductus Arteriosus (S-19) (Pg. 414)

2. CyanoticSpell in Tetralogy of Fallot- treatment (S-16) (Pg. 419)
3. Acute Rheumatic Fever* - Jones esCriteria; management (W-15)(S-06) (Pg. 432)
-
4. Congestive Cardiac Failure*** management*; symptoms, signs (S-15)(W-09) (S-07)(W-02) (Pg. 395)
5. Hypercyanotic Spells* and its Treatment (S-14)(W-03) (Pg. 408)
-
6. Infective Endocarditis prevention, management (S-10) (Pg. 441)

LAQ,
X
(hemodynanmics& c/f) (cyanotic heart ds, with respiratory distress)
1. Tetralogy of Fallot - describe components, Cyanotic Spell - management (S-20) (Pg. 417, 408)
2. Acute Rheumatic Fever***** in an 8 y/o child - etiology", c/f****, management*****;
etiopathology*;diagnosis*, prevention; investigation (W-13)(W-10)(S-09) (W-07)(S-07)(S-03) (Pg. 430)

17:Disorders of Kidney and Urinary Tract

SAQ
(etiology & management)
-
1. Acute Febrile [Urinary Tract Infection]** in 1 y/o child investigations*; diagnostic approach (W-18)(S
16)(W-13) (Pg. 479)
2. NephroticSyndrome* - management of first attack; complications (S-18) (W-05) (Pg. 474)
3. Acute Glomerulonephritis* -management (S-17)(W-10)(Pg.470)
4. Nocturnal* [Enuresis]* (S-15)(S-09)(S-06) (Pg. 499)
5. Vesico-Ureteric Reflux (W-12) (Pg. 480)
6. Minimal Change Disease & Acute Post-Streptococcal Glomerulonephritis - compare c/f, laboratory
features, complications (S-06)

LAQ

1. Acute Glomerulonephritis**** (AGN) in 5 y/o* child weighing 15 kgs- define*, c/f** D/D;
investigations*, treatment*; management*, complications, pathology; etiology, diagnosis (W-19)
(W-15)(S-13) (S-08) (S-05) (Pg. 469)
2. Anasarca in Childrencauses (part) (S-192yo childwith oliguria:approach
3. Nephrotic Syndrome**; First Attack of Minimal Change NS - c/f***, diagnosis, management***;
define; etiopathogenesis, investigations*; pathology (S-19)(W-16) (S-16)(W-03) (Pg. 472)
4. Haematuria** - define; causes in 7 y/o;evaluation in 5 y/o (part) (W-17)(W-15)(W-14) (Pg. 466)
5. Acute Post-Streptococcal Glomerulonephritis** - c/f, laboratory findings, management**;
investigations (W-17)(W-14)(W-04) (Pg. 469)
6. Acute Nephritic Syndrome - definition, etiology,c/t, investigations, management (W-12) (Pg. 469)
 18: Endocrine & Metabolic Disorders
SAQ

-
1. Diabetic Ketoacidosis* fluid management; treatment (S-20)(W-13) (Pg. 547)
2. Congenital Hypothyroidism (W-19) (Pg. 511)
3. Cretinism (W-06) (Pg. 515)

LAQ T1DM: diagnostic criteria, dietary management, insulin therapy

1. Hypothyroidism in children - c/f, investigations, management (W-02) (Pg. 511)
(congenital)

19: Diseases of Central Nervous System

SAQ

-
1. Cerebral Palsy definition, classification (S-18) (Pg. 565)
imple
X2. Febrile Seizures*; Atypical Febrile Seizures; Febrile Convulsions** - management (S-15) (S-13)(S-12)
(w-06)(5-05)(S-04) (Pg. 554)
3. Pyogenic Meningitis - laboratory diagnosis (S-14) (Pg. 562)vs Tubercular meningitis
4. Child with Generalized Tonic Clonic Convulsion - management (W-10) (Pg. 556)
5. Cerebrospinal Fluid Examination (W-09) (Pg. 562)
6. Breath Holding Spell** (S-08)(W-07)(W-04) (Pg. 555)

LAQ

1. y/o child -fever, recurrent seizures of 1 day duration - causes (part) (W-19)
3
2. Acute [Pyogenic Meningitis] ** - investigations*, management**; etiology, c/f (W-19) (W-13) (W-03)
(Pg. 561)
3. Tubercular Meningitis - etiopathogenesis, c/f, management (W-16) (Pg. 562)
4. Convulsions in children; 5 y/o child - causes; D/D; Status Epilepticus - management (S-14)(W-03) (Pg.
553) Define, classify epilepsy and
y/o male child - fever, altered sensorium, seizures etiology, D/D, management, complications (W
-
5. 2
12)(Pg. 554)
6. Typical Febrile Convulsion - describe, stepwise management, prevention (W-11) (Pg. 553)

20: Neuromuscular Disorders

SAQ

1. Guillian Barre Syndrome* - clinical presentation (S-17)(W-16) (Pg. 585)

2. Acute Flaccid Paralysis* (AFP) Surveillance (W-10)(W-03) (Pg. 586)
LAQ

Acute Flaccid Paralysis** in children/4 y/o child -causes; D/D, management; define, classification; AFP
Surveillance (S-19)(W-08)(S-04) (Pg. 586)
2. Acute Guillian Barre Syndrome- diagnosis, management (S-19) (Pg. 585)
and C/f

23: Genetic Disorders

SAQ

1. Down's Syndrome** -antenatal diagnosis (W-14)(S-10) (S-09) (Pg. 635)

2. Turner's Syndrome* (W-07)(S-04) (Pg. 637)

26:Skin Disorders
Kawasaki Disease: management
SAQ

1. EM - age independent criteria for diagnosis (W-18) (Pg. 691)

27:Poisonings, Injuries and Accidents

SAQ

1. Kerosene Poisoning (W-08) (Pg. 712)

31: Integrated Management of Neonatal and Childhood llness

SAQ

1. [Assessment of a Sick Infant with Diarrhoea as per IMNCISyndromic Approach]* (W-19) (S-13) (Pg. 288,
781)
2. Fever in a 3 y/o- classify as per IMNCIguidelines (W-15) (Pg. 206, 782)
3. 2 y/o child presenting with Cough and Fever - management as per IMNCI protocol (W-12)

LAQ

a PHC -
1. Febrile 3 y/ochild at IMNCI approach (S-12)

3yo child with cough & fever since 3 days. HR 102, RR

48 and mild lower chest retraction, normal saturation:
Classify illness and treatment plan as per WHO
32: Rights of Children
SAQ

1. Child Abuse (W-18) (Pg. 788)

2. Rights of Children (W-17) (Pg. 787)

Untitled
SAQ

1. Anaphylaxis - management (W-17)

2. Immunization of a child with Hemophilia (W-12)
3. Peripheral Blood Smear Examination (W-11)
4. Under-five Clinic (S-09)
5. Hydrops Fetalis (S-03)

LAQ

previously well 3 y/o child acute onset fever, cough, breathlessness, refusal to feed - D/D,
-
1. A
investigations, management (S-10)